Diplopia

H7_DIPLOPIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53.2 Hospital discharge: ICD-9 — 3682 Cause of death: ICD-10 — H53.2 Cause of death: ICD-9 — 3682 2 out of 7 registries used, show all original rules.	5731
4. Check minimum number of events None	5731
5. Include endpoints None	5731
6. Filter based on genotype QC (FinnGen only)	5533

Control definitions (FinnGen only)

Control exclude: H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H53
Name in latin: Diplopia

NAME	H7_DIPLOPIA
CONTROL_EXCLUDE	H7_VISUALDISTBLIND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H532
HD_ICD_9	3682
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H532
COD_ICD_9	3682
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diplopia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31915	16114	15679
Only index persons	29817	15235	14582
Unadjusted period prevalence (%)
Whole population	0.45	0.46	0.44
Only index persons	0.56	0.56	0.56
Median age at first event (years)
Whole population	58.10	57.83	58.33
Only index persons	57.67	57.47	57.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5533	3064	2469
Unadjusted period prevalence (%)	1.11	1.09	1.13
Median age at first event (years)	59.30	56.38	62.93

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5731: Matched controls
57310

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

62.7

307.7

509

H53.2

ICD-10 Finland

Diplopia

70704.1

307.7

5685

100

H53.1

ICD-10 Finland

Subjective visual disturbances

16.1

307.7

822

590

XCW99

NOMESCO Finland

Other investigative procedure of eye

5.3

307.7

1369

3206

AA1AD

NOMESCO Finland

CT of head and brain

3.8

307.7

2538

9966

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.1

307.7

1056

2449

H50.2

ICD-10 Finland

Vertical strabismus

31.6

307.7

283

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.4

307.7

1592

5786

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.5

307.7

1036

2229

H50.52

ICD-10 Finland

Exophoria

18.1

307.7

268

155

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

39.2

307.7

219

XCK00

NOMESCO Finland

Perimetry

5.6

307.7

755

1516

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

55.9

307.7

322

H53.4

ICD-10 Finland

Visual field defects

41.4

266.9

161

TAB00

NOMESCO Finland

Lumbar puncture

5.5

248.4

514

1016

R51.80

ICD-10 Finland

Headache

3.1

247.8

1289

4919

CE2W4

NOMESCO Finland

Eye movement mapping

116.1

245.1

125

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

6.6

230.9

384

614

R42

ICD-10 Finland

Dizziness and giddiness

2.6

226.9

1750

8179

H50.0

ICD-10 Finland

Convergent concomitant strabismus

18.8

214.2

170

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.6

214.1

780

2377

N07AA02

ATC

pyridostigmine; systemic

21.2

211.5

159

H53.9

ICD-10 Finland

Visual disturbance, unspecified

7.6

208.1

303

419

G70.0

ICD-10 Finland

Myasthenia gravis

26.0

204.6

142

G35

ICD-10 Finland

Multiple sclerosis

9.3

193.2

237

266

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

16.4

189.7

161

101

H50.31

ICD-10 Finland

Intermittent exotropia

15.6

189.2

165

109

H50.51

ICD-10 Finland

Esophoria

22.3

175.5

129

CEC00

NOMESCO Finland

Recession of extraocular muscle

27.9

170.1

115

108

Kela drug reimbursment

Myasthenia gravis

27.8

165.5

112

H50.1

ICD-10 Finland

Divergent concomitant strabismus

14.9

165.0

147

101

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

12.0

164.5

167

143

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.1

163.4

779

2781

109

Kela drug reimbursment

Multiple sclerosis

10.2

158.1

179

180

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

156.3

2941

19279

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

12.1

155.7

157

133

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

14.6

155.5

140

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

153.0

796

2979

H50.30

ICD-10 Finland

Intermittent esotropy

24.7

144.5

102

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

14.6

144.3

130

F05

ICPC

Visual disturbance other

5.2

143.2

305

614

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

5.5

139.5

278

527

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

6.3

138.7

238

391

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.4

137.2

356

843

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.1

135.4

624

2174

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.1

118.3

340

869

N03AX16

ATC

[U] pregabalin

2.0

111.3

1507

8530

H53.3

ICD-10 Finland

Other disorders of binocular vision

36.7

110.9

N03AX09

ATC

lamotrigine; oral

3.6

109.9

376

1085

XA800

NOMESCO Finland

Neuropsychological investigation

3.8

108.1

349

968

N03AX12

ATC

[U] gabapentin; oral

2.2

107.7

1101

5594

B01AC04

ATC

clopidogrel; oral

2.2

105.6

1086

5527

G44.2

ICD-10 Finland

Tension-type headache

2.3

105.6

903

4258

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.1

103.1

469

1614

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.0

95.8

445

1548

Z3231

NOMESCO Finland

Registered nurse

1.9

95.6

1695

10428

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

11.0

94.7

101

N02AX02

ATC

tramadol; systemic, rectal

1.8

94.1

2544

17768

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

94.1

2499

17366

PA6AD

NOMESCO Finland

CT of neck arteries

4.2

93.0

255

628

S06.0

ICD-10 Finland

Concussion

2.4

92.2

730

3316

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.7

88.8

520

2047

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

16.6

88.3

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

8.1

88.2

119

150

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

87.8

732

3396

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

84.4

596

2566

R53

ICD-10 Finland

Malaise and fatigue

1.9

82.8

1441

8746

H50.9

ICD-10 Finland

Strabismus, unspecified

19.6

82.5

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.7

82.4

267

741

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

81.8

988

5297

L03AX13

ATC

glatiramer acetate; parenteral

13.2

81.0

R06.0

ICD-10 Finland

Dyspnoea

1.8

80.8

1609

10165

A02BC02

ATC

pantoprazole; systemic

1.7

80.1

3873

31215

L03AB07

ATC

interferon beta-1a; parenteral

10.5

79.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

79.4

2092

14310

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

22.1

77.3

CS494

NOMESCO Finland

Other visual field testing

4.2

77.2

211

518

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

77.2

1079

6078

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

76.5

441

1718

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

75.5

465

1872

H51.1

ICD-10 Finland

Convergence insufficiency and excess

16.8

75.4

CEC30

NOMESCO Finland

Resection of extraocular muscle

36.4

75.2

N02BE01

ATC

paracetamol; systemic, rectal

2.2

75.1

5085

44917

H02AB06

ATC

prednisolone; systemic

1.7

73.2

2703

20087

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

70.8

1640

10750

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

70.1

1680

11111

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

5.0

70.0

152

310

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

13.7

69.8

H46

ICD-10 Finland

Optic neuritis

9.0

69.6

N03AG01

ATC

valproic acid; systemic, rectal

2.7

69.4

392

1510

N17

ICPC

Vertigo/dizziness

2.1

69.2

764

3944

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

68.3

370

1395

N06AX16

ATC

venlafaxine; oral

2.0

68.0

833

4466

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

6.1

67.9

118

196

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

9.9

67.8

M79.6

ICD-10 Finland

Pain in limb

1.6

67.6

2333

16933

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

66.7

1324

8284

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

9.6

66.6

N06AX11

ATC

mirtazapine; oral

1.7

66.2

1908

13214

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

64.4

1270

7920

H57.1

ICD-10 Finland

Ocular pain

3.2

64.3

264

852

H52.5

ICD-10 Finland

Disorders of accommodation

27.1

62.8

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.5

62.6

413

1715

M54.5

ICD-10 Finland

Low back pain

1.6

62.6

1987

14054

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.3

62.4

165

395

H53.8

ICD-10 Finland

Other visual disturbances

6.5

62.0

101

157

164

Kela drug reimbursment

Fingolimod

15.7

61.5

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.5

61.3

217

638

R02

ICPC

Shortness of breath/dyspnoea

2.0

60.4

776

4217

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

60.1

1758

12158

H50.8

ICD-10 Finland

Other specified strabismus

20.2

60.0

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

59.9

312

1151

H53.0

ICD-10 Finland

Amblyopia ex anopsia

14.3

59.6

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

7.4

59.2

118

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

59.1

812

4512

N01

ICPC

Headache

2.1

59.1

642

3285

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

58.7

1082

6593

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

58.3

724

3885

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

58.3

975

5768

N06AX21

ATC

duloxetine; oral

2.0

58.2

687

3622

H05.2

ICD-10 Finland

Exophthalmic conditions

15.8

58.0

H02.4

ICD-10 Finland

Ptosis of eyelid

3.4

57.7

217

663

L04AX07

ATC

dimethyl fumarate; oral

12.2

57.3

N05AH04

ATC

quetiapine; oral

1.8

57.2

990

5915

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

5.6

57.2

109

198

G51.0

ICD-10 Finland

Bell palsy

3.5

57.1

205

608

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

4.9

57.0

127

265

R4110

NOMESCO Finland

Physiotherapy

1.6

56.3

1547

10496

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

56.1

315

1208

N03AF02

ATC

oxcarbazepine; oral

3.2

55.8

233

759

N03AE01

ATC

clonazepam; systemic

2.5

55.5

368

1530

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

55.5

932

5513

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

19.7

55.5

A04

ICPC

Weakness/tiredness general

1.9

55.3

866

5014

N86

ICPC

Multiple sclerosis

8.0

54.9

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

54.8

510

2455

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

20.1

54.7

Z2445

NOMESCO Finland

Psychologist

3.0

54.5

251

865

L03AB08

ATC

interferon beta-1b; parenteral

14.7

53.6

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

14.1

53.6

3682A

ICD-9 Finland

Visual disturbances, Diplopia

+∞

53.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

53.0

2297

17296

L04AA27

ATC

[U] fingolimod

17.3

52.3

Z3226

NOMESCO Finland

Physiotherapist

1.7

52.3

1034

6408

353

Kela drug reimbursment

Cladribine and fingolimod

15.0

51.9

R51

ICD-10 Finland

Headache

2.5

51.7

334

1372

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

51.5

331

1356

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

51.3

597

3124

N03AX11

ATC

topiramate; oral

3.6

51.0

171

485

ZXA10

NOMESCO Finland

Bilateral

1.7

50.7

1054

6618

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

50.5

2425

18607

N05CF01

ATC

zopiclone; oral

1.6

50.5

1762

12602

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

50.3

1443

9849

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

50.3

577

3004

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

49.8

1955

14346

A02BC05

ATC

esomeprazole; systemic

1.5

49.7

2200

16574

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

49.7

383

1704

J01DB01

ATC

cefalexin; oral

1.7

49.6

4587

40519

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

49.0

321

1327

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.8

48.9

249

907

C07AB07

ATC

bisoprolol; oral

1.5

48.9

2639

20708

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

48.5

563

2941

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.1

48.4

134

332

R03AC02

ATC

salbutamol; inhalant

1.5

48.4

2939

23611

M03BX01

ATC

baclofen; systemic

3.8

48.2

147

391

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

48.0

327

1376

R13

ICD-10 Finland

Dysphagia

2.2

47.8

431

2046

M25.5

ICD-10 Finland

Pain in joint

1.6

47.8

1700

12179

S18

ICPC

Laceration/cut

1.5

47.7

2489

19357

R55

ICD-10 Finland

Syncope and collapse

1.9

47.6

644

3545

N05BA04

ATC

oxazepam; oral

1.6

47.4

1408

9671

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

47.3

958

5961

C10AA05

ATC

atorvastatin; oral

1.5

47.1

2239

17065

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

47.1

465

2288

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

47.0

1793

13038

C07AA05

ATC

propranolol; systemic

1.7

46.6

1081

6975

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

46.3

277

1096

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

46.3

754

4402

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

46.2

1041

6662

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

46.1

424

2029

L28

ICPC

Limited function/disability (L)

1.7

46.0

989

6252

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

45.7

3851

32905

ZXD05

NOMESCO Finland

Urgent procedure

1.6

45.6

1641

11762

N06AB04

ATC

citalopram; systemic

1.7

45.6

1128

7396

UKC02

NOMESCO Finland

Cystoscopy

1.7

45.4

905

5602

A28

ICPC

Limited function/disability NOS

1.7

45.3

960

6040

M03BX02

ATC

tizanidine; oral

1.5

45.2

3270

27052

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.9

45.1

204

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.3

45.0

175

546

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.4

44.7

160

474

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

44.5

796

4775

UJF32

NOMESCO Finland

Coloscopy

1.6

44.3

1417

9879

L03

ICPC

Low back symptom/complaint

1.6

44.1

1479

10420

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

44.0

1197

8026

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

44.0

957

6060

F29

ICPC

Eye symptom/complaint other

2.0

44.0

530

2802

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

42.8

321

1409

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

42.7

700

4087

L17

ICPC

Foot/toe symptom/complaint

1.5

42.6

1540

11017

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.0

42.2

187

631

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

41.9

2212

17105

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

41.9

165

519

A11

ICPC

Chest pain NOS

2.0

41.9

475

2457

C03CA01

ATC

furosemide; systemic

1.5

41.7

1598

11571

H062, E050,

ICD-10 Finland

14.2

41.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

41.6

1548

11137

Z2446

NOMESCO Finland

Social worker

2.2

41.5

373

1766

R52.2

ICD-10 Finland

Other chronic pain

2.7

41.2

232

890

J01MA02

ATC

ciprofloxacin; systemic

1.5

40.9

2079

15936

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

40.7

1378

9700

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

40.7

2897

23681

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

40.6

1000

6528

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.5

40.6

143

ZXA05

NOMESCO Finland

Left side

1.6

40.5

1310

9124

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

40.2

955

6174

N06AB10

ATC

escitalopram; oral

1.6

40.0

1054

6995

R11

ICD-10 Finland

Nausea and vomiting

2.0

39.9

490

2604

N05BA01

ATC

diazepam; systemic, rectal

1.8

39.8

707

4223

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.6

39.4

235

928

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

38.9

531

2924

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.8

38.9

124

N06AB03

ATC

fluoxetine; oral

1.8

38.8

656

3861

N06AA09

ATC

amitriptyline; systemic

1.9

38.7

535

2959

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

38.6

333

1550

H02AB07

ATC

prednisone; oral

1.7

38.5

745

4556

N05AX12

ATC

aripiprazole; systemic

2.6

38.5

223

868

N02AA05

ATC

oxycodone; systemic

1.6

38.4

949

6190

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.3

38.1

144

442

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

38.1

552

3099

R50.9

ICD-10 Finland

Fever, unspecified

1.7

37.9

810

5089

N03AF01

ATC

carbamazepine; oral, rectal

2.3

37.7

293

1306

R52.9

ICD-10 Finland

Pain, unspecified

1.9

37.6

530

2948

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.3

37.5

140

426

WX002

NOMESCO Finland

Sedation and analgesia

1.6

37.5

1035

6933

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

37.4

1919

14673

N02BF01

ATC

gabapentin; oral

2.0

37.3

454

2404

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

55.4

37.3

R4120

NOMESCO Finland

Occupational therapy

2.1

37.1

370

1824

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

36.7

664

3981

H03AA01

ATC

levothyroxine sodium; systemic

1.5

36.6

1214

8476

Z71.8

ICD-10 Finland

Other specified counselling

1.5

36.6

1583

11693

N04BC05

ATC

pramipexole; oral

2.0

36.5

431

2259

SPAT1301

SPAT

No procedures

1.5

36.4

1662

12407

ZXE00

NOMESCO Finland

One hour or less

1.4

36.2

2027

15731

A01

ICPC

Pain general/multiple sites

1.9

36.1

503

2786

A02BC01

ATC

omeprazole; systemic

1.5

35.8

1440

10469

SPAT1263

SPAT

Sampling

1.4

35.8

2212

17473

H03BB01

ATC

carbimazole; oral

2.4

35.7

243

1022

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

35.6

643

3854

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

35.5

242

1018

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

35.4

2734

22452

R60.0

ICD-10 Finland

Localized oedema

1.7

35.4

666

4036

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

35.4

254

1094

2AB04, ,

NOMESCO Finland

10.3

35.1

Z2221

NOMESCO Finland

Medical doctor

1.5

35.1

1420

10332

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.4

35.0

127

380

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

35.0

210

832

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.0

34.9

246

N03AX14

ATC

levetiracetam; systemic

2.8

34.8

177

644

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.5

34.7

192

R07.3

ICD-10 Finland

Other chest pain

1.8

34.7

542

3110

H47.2

ICD-10 Finland

Optic atrophy

10.9

34.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

34.6

709

4398

G47.3

ICD-10 Finland

Sleep apnoea

1.5

34.5

1163

8137

ZY010

NOMESCO Finland

Hospital outpatient

2.3

34.3

281

1280

W19

ICD-10 Finland

Unspecified fall

1.8

34.3

533

3053

G45.3

ICD-10 Finland

Amaurosis fugax

3.7

34.3

111

308

M79.1

ICD-10 Finland

Myalgia

1.7

34.2

745

4697

CEW99

NOMESCO Finland

Other operation on extraocular muscle

42.3

34.0

H54.7

ICD-10 Finland

Unspecified visual loss

7.8

34.0

N02BF02

ATC

pregabalin; oral

2.1

33.7

329

1608

J01FF01

ATC

clindamycin; systemic

1.5

33.6

1401

10238

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

33.5

329

1611

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.6

33.5

199

784

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.1

33.5

227

J01AA02

ATC

doxycycline; systemic

1.5

33.5

4134

36708

WX892

NOMESCO Finland

Monitored bed care

1.9

33.4

416

2220

H52.1

ICD-10 Finland

Myopia

2.6

33.2

195

764

J01EA01

ATC

trimethoprim; systemic

1.5

33.2

1340

9726

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

33.1

1973

15420

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

33.0

2004

15713

N30.0

ICD-10 Finland

Acute cystitis

1.6

32.8

842

5528

R05

ICPC

Cough

1.5

32.7

1226

8762

N06AB06

ATC

sertraline; oral

1.8

32.6

581

3464

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

8.5

32.6

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

32.6

1126

7909

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.2

32.4

211

H52.2

ICD-10 Finland

Astigmatism

3.3

32.4

122

374

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.9

32.2

149

515

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

32.2

3747

32777

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

32.1

954

6478

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.3

32.1

196

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

32.0

1211

8664

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

32.0

714

4525

R01AD09

ATC

mometasone; nasal

1.4

31.8

2302

18575

R06AE07

ATC

cetirizine; oral

1.4

31.8

2248

18067

A06AD11

ATC

lactulose; oral

1.6

31.8

776

5028

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

31.8

381

2006

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

31.7

235

1026

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.3

31.7

123

384

A02BC03

ATC

lansoprazole; oral

1.5

31.6

1462

10882

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

31.4

1476

11020

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

31.4

1031

7157

183

Kela drug reimbursment

Lamotrigin and topiramate

5.0

31.1

136

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

30.9

206

858

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

30.8

608

3727

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

30.8

564

3388

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.5

30.7

165

L12

ICPC

Hand/finger symptom/complaint

1.6

30.7

832

5527

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

30.7

663

4164

P76

ICPC

Depressive disorder

2.0

30.6

338

1729

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

30.2

273

1294

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

30.1

475

2730

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

30.1

1242

9029

R51.81

ICD-10 Finland

Facial pain NOS

2.9

30.1

147

524

P03

ICPC

Feeling depressed

1.8

30.0

484

2801

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

29.9

472

2713

SPAT1240

SPAT

Therapeutic discussion

1.8

29.9

525

3114

P01AB01

ATC

metronidazole; oral, rectal

1.4

29.8

1994

15829

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

29.7

420

2333

K02.1

ICD-10 Finland

Caries of dentine

1.4

29.7

3009

25557

G43.3

ICD-10 Finland

Complicated migraine

3.5

29.5

101

291

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

29.4

1173

8464

S80.0

ICD-10 Finland

Contusion of knee

1.9

29.4

381

2058

C10AA01

ATC

simvastatin; oral

1.4

29.4

2154

17352

D01

ICPC

Abdominal pain/cramps general

1.7

29.2

595

3678

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

29.0

790

5250

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

29.0

1274

9369

L01

ICPC

Neck symptom/complaint

1.6

28.8

777

5150

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

28.7

276

1340

N05AH03

ATC

olanzapine; systemic

2.0

28.7

326

1684

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

28.6

140

500

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

28.6

1571

12034

XF404

NOMESCO Finland

Ambulatory ECG

1.8

28.5

464

2692

XKD00

NOMESCO Finland

Uroflowmetry

1.6

28.4

818

5502

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

28.3

2363

19400

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

28.2

948

6599

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.3

28.1

106

325

D11

ICPC

Diarrhoea

1.7

28.1

586

3641

N18

ICPC

Paralysis/weakness

3.0

28.1

125

423

X58

ICD-10 Finland

Exposure to other specified factors

1.6

28.0

707

4609

SPAT1260

SPAT

Consultation of another employee

1.5

28.0

903

6230

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

27.9

506

3027

N28

ICPC

Limited function/disability (N)

3.2

27.8

111

353

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.2

27.7

179

H02AB04

ATC

methylprednisolone; systemic

1.6

27.5

730

4815

L04AA31

ATC

[U] teriflunomide

8.6

27.5

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

27.5

436

2509

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

27.4

523

3172

J01CA04

ATC

amoxicillin; systemic

1.4

27.4

4371

39704

G04BD12

ATC

mirabegron; oral

1.6

27.3

617

3913

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

3.6

27.2

254

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.1

27.2

112

363

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.7

27.1

231

B01AB05

ATC

enoxaparin; parenteral

1.4

27.1

1606

12440

H26.4

ICD-10 Finland

After-cataract

1.7

27.1

505

3043

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

27.1

344

1845

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

27.1

705

4629

H50.6

ICD-10 Finland

Mechanical strabismus

38.0

27.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

27.0

591

3717

J01FA10

ATC

azithromycin; systemic

1.4

27.0

2894

24636

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

26.8

417

2385

CA1AD

NOMESCO Finland

Orbita CT

9.7

26.8

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

26.8

455

2672

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

26.6

2365

19552

SPAT1097

SPAT

Recording of ECG

1.6

26.6

754

5050

G50.1

ICD-10 Finland

Atypical facial pain

3.2

26.6

107

342

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

26.6

1713

13453

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

26.5

172

708

U02

ICPC

Urinary frequency/urgency

1.6

26.5

704

4645

R00.2

ICD-10 Finland

Palpitations

1.8

26.4

387

2173

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

26.3

176

734

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

7.3

26.3

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

26.3

162

651

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.1

26.2

109

355

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

26.2

830

5697

ZXA00

NOMESCO Finland

Right side

1.4

26.2

1335

10064

D06

ICPC

Abdominal pain localized other

1.8

26.1

436

2546

K90

ICPC

Stroke/cerebrovascular accident

2.5

26.1

164

665

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

26.0

210

L04AX01

ATC

azathioprine; systemic

2.2

26.0

227

1062

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

26.0

597

3801

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

25.9

459

2726

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

25.9

1315

9900

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

31.1

25.9

N06AX12

ATC

bupropion; oral

1.9

25.8

335

1810

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

25.8

1131

8288

N05CF02

ATC

zolpidem; oral

1.5

25.7

851

5893

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

25.6

1385

10543

L08

ICPC

Shoulder symptom/complaint

1.5

25.6

1089

7933

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

25.3

221

1034

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.3

25.3

153

K59.0

ICD-10 Finland

Constipation

2.0

25.3

297

1552

H02AB09

ATC

hydrocortisone; systemic

2.7

25.2

137

517

H50.59

ICD-10 Finland

Heterophor UNS

35.7

25.2

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

5.5

25.0

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

4.9

25.0

114

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

25.0

1186

8814

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

25.0

868

6071

WX402

NOMESCO Finland

General anaesthesia

1.5

24.9

1030

7457

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.3

24.9

289

J01DA01

ATC

[U] cefalexin

1.3

24.8

3176

27613

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

24.7

1828

14639

B01AA03

ATC

warfarin; systemic

1.5

24.7

950

6782

P06

ICPC

Sleep disturbance

1.6

24.6

569

3625

C09AA05

ATC

ramipril; oral

1.4

24.6

1246

9363

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

24.6

567

3610

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.0

24.6

109

369

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

24.5

686

4574

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.2

24.5

312

M48.0

ICD-10 Finland

Spinal stenosis

1.6

24.5

621

4047

R35

ICD-10 Finland

Polyuria

1.8

24.3

356

1998

PA2AD

NOMESCO Finland

CT angiography of brain

4.4

24.3

141

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

24.3

725

4906

SFA10

NOMESCO Finland

One-surface restoration

1.3

24.3

2763

23581

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

24.2

1085

7971

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

24.2

1310

9957

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

24.1

250

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

24.1

274

1415

H01

ICPC

Ear pain/earache

1.6

24.1

553

3518

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.8

24.0

114

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

24.0

454

2745

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.4

24.0

251

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

23.9

243

1206

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.0

23.9

173

H50.4

ICD-10 Finland

Other and unspecified heterotropia

22.8

23.8

C08DA01

ATC

verapamil; systemic

2.1

23.8

218

1039

U07

ICPC

Urine symptom/complaint other

1.8

23.8

380

2190

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

23.8

310

1677

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

23.8

204

948

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

23.7

230

1121

P29

ICPC

Psychological sympt/compl other

1.8

23.7

335

1861

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.9

23.6

108

372

J01MA12

ATC

levofloxacin; systemic

1.5

23.6

922

6597

ZX120

NOMESCO Finland

Intravenous

1.7

23.5

478

2947

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.0

23.5

105

357

H53

ICD-10 Finland

Visual disturbances

4.5

23.3

125

N29

ICPC

Neurological sympt/complt other

2.8

23.3

118

430

SPAT1254

SPAT

Administration of medicine

1.5

23.2

756

5209

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

23.1

131

506

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

23.0

1526

11984

N06AX26

ATC

vortioxetine; oral

1.8

22.9

348

1975

S06.3

ICD-10 Finland

Focal brain injury

3.3

22.7

255

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.8

22.7

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

22.7

426

2571

S29

ICPC

Skin symptom/complaint other

1.5

22.6

946

6851

N05CD07

ATC

temazepam; oral

1.6

22.6

568

3690

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.5

22.6

138

552

R03BA05

ATC

fluticasone; inhalant

1.5

22.6

883

6312

M01AB05

ATC

diclofenac; systemic, rectal

1.3

22.6

3380

29850

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

22.4

175

782

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

22.4

757

5255

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

22.4

212

1025

EBA00

NOMESCO Finland

Extraction of tooth

1.3

22.3

1763

14211

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

22.3

1974

16182

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

22.3

103

357

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

22.3

374

2187

M79.7

ICD-10 Finland

Fibromyalgia

2.3

22.2

175

785

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

7.9

22.1

N07XX09

ATC

[U] dimethyl fumarate

9.0

22.1

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

22.1

504

3200

N07CA01

ATC

betahistine; oral

1.8

22.0

371

2171

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.0

22.0

252

1305

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

22.0

1233

9406

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

22.0

319

1785

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

21.9

311

1729

SPAT1229

SPAT

Assessment of need for aid

1.7

21.9

391

2327

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

21.9

896

6461

G44.0

ICD-10 Finland

Cluster headache syndrome

3.5

21.8

208

XF402

NOMESCO Finland

ECG with work load test

1.6

21.8

529

3409

G04CA02

ATC

tamsulosin; oral

1.4

21.8

1143

8622

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

21.7

331

1882

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

21.7

599

3979

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

21.6

536

3470

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

21.6

141

582

M01AE02

ATC

naproxen; oral, rectal

1.3

21.5

2845

24623

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.9

21.5

159

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

21.5

495

3148

J01FA06

ATC

roxithromycin; oral

1.3

21.5

1952

16038

L86

ICPC

Back syndrome with radiating pain

1.8

21.4

303

1683

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

21.4

138

567

N06BA07

ATC

modafinil; oral

6.4

21.3

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

21.3

138

568

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

21.3

105

377

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

21.2

161

711

Z01.2

ICD-10 Finland

Dental examination

1.3

21.2

2213

18534

A98

ICPC

Health maint/preventive medicine

1.7

21.2

5400

51776

ZXY02

NOMESCO Finland

Neuropsychologist

5.1

21.1

K07.60

ICD-10 Finland

Snapping jaw

2.0

21.0

246

1285

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

20.9

595

3977

R01AD08

ATC

fluticasone; nasal

1.4

20.9

1382

10818

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

20.9

289

1594

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

20.9

615

4143

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

20.8

207

1019

L15

ICPC

Knee symptom/complaint

1.4

20.8

1145

8697

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

20.8

117

450

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.1

20.8

285

SPAT1216

SPAT

Assessment of functional ability

1.5

20.8

761

5364

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

20.8

494

3166

N05BA09

ATC

clobazam; oral

5.2

20.8

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

20.7

482

3072

S09.9

ICD-10 Finland

Unspecified injury of head

3.0

20.7

312

SPAT1050

SPAT

Extensive neurological examination

2.5

20.7

126

504

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

20.7

438

2727

SPAT1310

SPAT

Counselling related to known health issue

1.3

20.7

1575

12596

SPAT1312

SPAT

General health counselling

1.3

20.6

1568

12536

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.3

20.6

125

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

20.6

348

2038

D02

ICPC

Abdominal pain epigastric

1.8

20.6

299

1674

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.9

20.6

M54.1

ICD-10 Finland

Radiculopathy

2.1

20.6

207

1024

R27.0

ICD-10 Finland

Ataxia, unspecified

5.8

20.5

R52.1

ICD-10 Finland

Chronic intractable pain

3.8

20.4

161

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

20.4

3363

29889

N06AA10

ATC

nortriptyline; systemic

2.6

20.4

113

432

H81.3

ICD-10 Finland

Other peripheral vertigo

2.3

20.3

149

649

ZXD35

NOMESCO Finland

Usual procedure

2.2

20.3

174

809

K30

ICD-10 Finland

Functional dyspepsia

1.6

20.3

533

3498

R05

ICD-10 Finland

Cough

1.4

20.3

1040

7803

SFA30

NOMESCO Finland

Three-surface restoration

1.3

20.2

2054

17104

C09CA06

ATC

candesartan; oral

1.4

20.2

1129

8592

M01AH01

ATC

celecoxib; oral

1.4

20.2

850

6153

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

20.2

317

1817

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

20.1

129

529

S22.3

ICD-10 Finland

Fracture of rib

1.7

20.1

355

2106

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

20.1

183

872

N04BB01

ATC

amantadine; oral

2.9

20.0

313

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

20.0

301

1704

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

19.8

420

2616

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

19.8

273

1505

A29

ICPC

General symptom/complaint other

1.5

19.7

617

4208

WX872

NOMESCO Finland

Intensive care

1.9

19.7

261

1420

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.8

19.7

156

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

19.7

680

4735

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

19.7

258

K08.3

ICD-10 Finland

Retained dental root

1.7

19.7

373

2256

N99

ICPC

Neurological disease other

3.2

19.6

253

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

19.6

137

584

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

19.6

166

768

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.8

19.6

161

R39.1

ICD-10 Finland

Other difficulties with micturition

2.2

19.6

166

769

A03

ICPC

Fever

1.5

19.5

771

5512

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

19.5

153

686

XKC03

NOMESCO Finland

Water cystometry

2.3

19.5

155

699

R03DC03

ATC

montelukast; oral

1.5

19.5

777

5565

R03BA02

ATC

budesonide; inhalant

1.4

19.4

845

6154

WZC30

NOMESCO Finland

Teaching

1.5

19.3

771

5523

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

19.3

258

1408

RS221, ,

NOMESCO Finland

3.0

19.3

282

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

15.6

19.2

J02AC01

ATC

fluconazole; systemic

1.3

19.2

1844

15210

R31

ICD-10 Finland

Unspecified haematuria

1.6

19.2

499

3267

G44.8

ICD-10 Finland

Other specified headache syndromes

3.0

19.1

278

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

19.1

348

2081

N05AA02

ATC

levomepromazine; systemic

2.0

19.1

199

997

C01DA14

ATC

isosorbide mononitrate; oral

1.5

19.1

735

5227

L04

ICPC

Chest symptom/complaint

1.8

19.1

306

1765

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

19.0

650

4513

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

6.0

19.0

A99

ICPC

Disease/condition unspecnature/site

1.6

18.9

454

2915

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

18.9

493

3228

H50.50

ICD-10 Finland

Alternating hyperphoria

14.8

18.9

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.4

18.8

199

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

18.8

341

2037

C10AC01

ATC

colestyramine; oral

2.3

18.8

139

608

R33

ICD-10 Finland

Retention of urine

1.7

18.7

392

2433

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

70.1

18.7

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

18.7

116

469

R21

ICPC

Throat symptom/complaint

1.4

18.7

946

7073

M54.3

ICD-10 Finland

Sciatica

1.8

18.6

296

1703

E0000UV, ,

ATC

1.3

18.6

2043

17139

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

18.6

590

4035

H49.9

ICD-10 Finland

Paralytic strabismus, unspecified

190.6

18.5

T74.1

ICD-10 Finland

Physical abuse

2.8

18.5

338

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

18.5

415

2621

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

18.5

1284

10098

W17

ICD-10 Finland

Other fall from one level to another

2.0

18.5

205

1051

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

18.4

414

2616

J05AB01

ATC

aciclovir; systemic

1.4

18.4

1034

7865

SFA20

NOMESCO Finland

Two-surface restoration

1.3

18.4

2883

25299

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.2

18.4

163

769

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

18.3

121

503

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.1

18.3

178

869

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

18.3

508

3373

H25.0

ICD-10 Finland

Senile incipient cataract

1.7

18.3

316

1862

Z00.0

ICD-10 Finland

General medical examination

1.4

18.3

937

7015

N05AX08

ATC

risperidone; systemic

1.6

18.3

391

2440

-1, ,

NOMESCO Finland

1.3

18.3

1590

12919

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

18.2

199

1014

D09

ICPC

Nausea

1.9

18.2

221

1168

G72.9

ICD-10 Finland

Myopathy, unspecified

3.7

18.2

151

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.5

18.2

184

XQ800

NOMESCO Finland

Prick test

1.7

18.2

338

2033

C08CA01

ATC

amlodipine; oral

1.3

18.1

1888

15714

F95

ICPC

Strabismus

21.8

18.1

R5110, ,

SPAT

1.7

18.1

319

1890

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

4.0

18.1

129

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

3.5

18.1

175

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

18.0

278

1586

C01CA24

ATC

epinephrine; parenteral

1.8

18.0

287

1653

WX140

NOMESCO Finland

Parabulbar anesthesy

1.9

18.0

225

1202

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.8

18.0

R74

ICPC

Upper respiratory infection acute

1.3

18.0

1437

11532

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.5

17.9

P20

ICPC

Memory disturbance

1.5

17.9

649

4557

B01AC07

ATC

dipyridamole; systemic

2.0

17.9

201

1034

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

17.9

223

1190

S21

ICPC

Skin texture symptom/complaint

1.5

17.8

682

4841

R03BA01

ATC

beclometasone; inhalant

1.5

17.8

662

4674

N30

ICD-10 Finland

Cystitis

1.7

17.8

372

2308

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

17.8

359

2207

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

17.8

249

1379

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

17.7

312

1848

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

17.7

224

1200

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

17.7

3052

27044

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

17.7

502

3351

S01.0

ICD-10 Finland

Open wound of scalp

1.6

17.6

387

2431

SPAT1153

SPAT

Removal of sutures

1.3

17.6

1543

12537

S97

ICPC

Chronic ulcer skin

1.8

17.6

294

1717

L02

ICPC

Back symptom/complaint

1.6

17.6

460

3014

R4110, ,

SPAT

1.6

17.5

414

2647

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

17.5

262

1481

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

17.5

936

7056

R03BB04

ATC

tiotropium bromide; inhalant

1.6

17.5

480

3180

K04.0

ICD-10 Finland

Pulpitis

1.6

17.4

421

2706

J45

ICD-10 Finland

Asthma

1.6

17.4

481

3189

KMAK, ,

NOMESCO Finland

1.3

17.4

2496

21603

C07AB02

ATC

metoprolol; systemic

1.4

17.4

948

7165

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.6

17.4

156

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

4.2

17.4

107

WX290

NOMESCO Finland

Other blockage of nerve

1.3

17.3

2223

18974

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

17.3

629

4418

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

17.3

368

2293

K08.80

ICD-10 Finland

Toothache NOS

1.6

17.3

391

2475

H93.1

ICD-10 Finland

Tinnitus

1.7

17.2

328

1985

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

17.1

530

3602

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

12.6

17.1

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

17.1

332

2021

N06AX03

ATC

mianserin; oral

1.9

17.1

227

1237

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.4

17.1

177

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

17.0

474

3149

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.1

17.0

113

L29

ICPC

Musculoskeletal sympt/complt other

1.6

17.0

407

2611

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

17.0

959

7289

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

17.0

530

3610

C10AX09

ATC

ezetimibe; oral

1.4

17.0

733

5321

TKC22

NOMESCO Finland

Catheterisation instruction

2.3

17.0

123

534

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

16.9

666

4751

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

16.9

390

2479

M01AH05

ATC

etoricoxib; oral

1.3

16.9

3051

27114

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.6

16.9

378

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

16.8

507

3426

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

16.8

343

2114

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.0

16.8

176

884

H29

ICPC

Ear symptom/complaint other

1.5

16.8

539

3692

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

16.8

296

1755

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

16.7

306

1832

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

16.7

363

2273

SGA01

NOMESCO Finland

Emergency treatment

1.4

16.7

732

5326

U01

ICPC

Dysuria/painful urination

1.6

16.7

362

2266

N89

ICPC

Migraine

2.1

16.6

148

700

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

16.6

1254

9964

R4130

NOMESCO Finland

Speech therapy

2.3

16.5

129

578

G91.1

ICD-10 Finland

Obstructive hydrocephalus

5.3

16.5

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

16.4

341

2111

A08

ICPC

Swelling

1.8

16.4

249

1413

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

16.4

297

1773

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

16.4

320

1950

C10AA07

ATC

rosuvastatin; oral

1.3

16.4

1496

12201

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

16.3

181

928

N05AE04

ATC

ziprasidone; systemic

4.5

16.3

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

16.3

438

2887

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

16.3

233

1300

N88

ICPC

Epilepsy

4.3

16.1

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

16.1

212

1151

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.3

16.1

115

496

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

16.1

346

2161

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

16.1

631

4496

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

16.1

293

1753

WX704

NOMESCO Finland

Intubation

1.6

16.0

373

2376

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

6.0

16.0

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

16.0

776

5745

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

16.0

325

2001

R03BA08

ATC

ciclesonide; inhalant

1.6

16.0

398

2578

UDM02

NOMESCO Finland

Sinoscopy

2.4

15.9

112

480

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

15.9

481

3252

R07.0

ICD-10 Finland

Pain in throat

1.7

15.8

311

1899

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

15.8

222

1231

U05

ICPC

Urination problems other

1.8

15.8

245

1401

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

15.8

119

526

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

15.8

715

5232

E23.00

ICD-10 Finland

Panhypopituitarism

5.5

15.7

S20.2

ICD-10 Finland

Contusion of thorax

1.8

15.7

246

1411

D12

ICPC

Constipation

2.0

15.7

176

907

SPAT1255

SPAT

Intravenous administration of medicine

1.6

15.7

332

2067

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

15.7

146

703

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

15.7

585

4130

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

15.6

426

2816

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

4.8

15.6

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.3

15.6

114

497

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

2.7

15.5

312

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.2

15.5

188

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.5

15.5

433

2877

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.5

15.4

389

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

15.4

124

563

D07AC01

ATC

betamethasone; topical

1.3

15.4

1737

14537

M54.2

ICD-10 Finland

Cervicalgia

1.6

15.4

360

2297

N03AB02

ATC

phenytoin; systemic

3.1

15.3

205

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

15.3

149

729

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

15.3

411

2707

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

12.3

15.3

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.4

15.3

165

J01DC02

ATC

cefuroxime; systemic

1.7

15.2

253

1475

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.9

15.2

238

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

4.9

15.2

L05

ICPC

Flank/axilla symptom/complaint

1.7

15.2

286

1727

A07AA02

ATC

nystatin; oral

1.7

15.2

278

1666

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.7

15.1

305

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.3

15.1

109

473

A02BA02

ATC

ranitidine; systemic

1.4

15.1

890

6802

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

15.1

164

836

R1260

NOMESCO Finland

Evaluation of communicative skills

2.6

15.1

323

A01AB09

ATC

miconazole; local oral

1.6

15.0

397

2605

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

45.1

15.0

B01AF02

ATC

apixaban; oral

1.4

15.0

593

4228

P01

ICPC

Feeling anxious/nervous/tense

1.5

15.0

503

3474

R06.4

ICD-10 Finland

Hyperventilation

2.7

15.0

295

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

15.0

1380

11244

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

15.0

137

655

S02.40

ICD-10 Finland

Fracture of malar and maxillary bones, closed

3.1

15.0

208

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

3.5

15.0

143

J01CA08

ATC

pivmecillinam; oral

1.3

14.9

1862

15760

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

14.9

1134

8999

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.7

14.9

296

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.9

14.9

111

A10AC01

ATC

insulin (human); parenteral

1.6

14.9

346

2204

L14

ICPC

Leg/thigh symptom/complaint

1.6

14.8

366

2366

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

14.8

1025

8026

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

14.8

1083

8549

N05AN01

ATC

lithium; oral

2.3

14.8

111

490

SPAT1325

SPAT

Vaccination

1.3

14.8

1630

13589

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

14.8

158

801

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

14.8

512

3561

3007

Kela drug reimbursment

Erenumab and fremanezumab

3.0

14.7

210

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

14.7

1018

7969

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.9

14.7

232

SPAT1262

SPAT

Handing over of treatment supplies

1.4

14.6

835

6345

R03AC03

ATC

terbutaline; inhalant

1.4

14.6

635

4608

H81.4

ICD-10 Finland

Vertigo of central origin

3.4

14.6

150

M05BA04

ATC

alendronic acid; oral

1.6

14.6

393

2590

G40

ICD-10 Finland

Epilepsy

3.4

14.6

155

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

14.6

1372

11205

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.8

14.6

249

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

14.5

450

3058

H47.1

ICD-10 Finland

Papilloedema, unspecified

4.3

14.5

K89

ICPC

Transient cerebral ischaemia

3.1

14.5

191

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

14.5

258

1534

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

14.5

986

7698

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

14.5

875

6709

N03AX18

ATC

lacosamide; systemic

3.7

14.5

118

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.5

14.5

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

14.4

297

1836

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

14.4

1241

10017

F31

ICD-10 Finland

Bipolar affective disorder

2.9

14.3

224

SPAT1104

SPAT

Monitoring of emergency patient

1.6

14.3

310

1940

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

14.3

927

7182

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

14.3

160

824

P74

ICPC

Anxiety disorder/anxiety state

1.9

14.3

186

1008

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

14.3

297

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

14.3

115

523

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

27.2

14.3

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

19.2

14.2

J01FA09

ATC

clarithromycin; systemic

1.3

14.2

1440

11868

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

14.2

296

1836

A05

ICPC

Feeling ill

1.7

14.2

271

1643

G93.2

ICD-10 Finland

Benign intracranial hypertension

13.4

14.2

N06AX22

ATC

agomelatine; oral

2.3

14.2

108

480

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.8

14.2

242

R15

ICD-10 Finland

Faecal incontinence

2.1

14.2

136

663

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

14.2

3423

31149

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

14.1

333

2128

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

14.1

689

5101

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

5.7

14.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

14.1

187

1019

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

14.1

188

1027

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.3

14.1

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.3

14.0

164

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.9

14.0

175

935

U04

ICPC

Incontinence urine

1.7

14.0

254

1518

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

14.0

159

823

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

14.0

281

1726

A10AB05

ATC

insulin aspart; parenteral

1.6

14.0

355

2309

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.4

14.0

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

14.0

332

2126

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

14.0

408

2738

SPAT1234

SPAT

Support of social functional capacity

1.7

13.9

242

1430

F34.1

ICD-10 Finland

Dysthymia

1.9

13.9

161

840

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

13.8

369

2428

R96

ICPC

Asthma

1.5

13.8

439

3000

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.9

13.7

159

829

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

13.7

430

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

13.7

307

1939

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

3.5

13.7

137

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.4

13.7

363

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

13.7

287

1783

R06.5

ICD-10 Finland

Mouth breathing

1.5

13.7

407

2743

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.2

13.6

113

521

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

13.6

172

924

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

13.6

359

2357

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

13.6

2009

17299

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

13.5

107

483

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

13.5

353

2310

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

13.5

2024

17451

R25.2

ICD-10 Finland

Cramp and spasm

2.2

13.5

115

536

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

13.5

255

1543

H57.0

ICD-10 Finland

Anomalies of pupillary function

4.1

13.4

J05AB11

ATC

valaciclovir; oral

1.4

13.4

644

4752

A97

ICPC

No disease

1.4

13.4

829

6375

R4140

NOMESCO Finland

Psychotherapy

4.2

13.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

13.4

398

2681

R5599

NOMESCO Finland

Other rehabilitation service

2.1

13.4

130

637

ZXD20

NOMESCO Finland

Day surgery

1.4

13.4

583

4232

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

13.4

250

Z00.8

ICD-10 Finland

Other general examinations

1.6

13.3

348

2278

H02

ICPC

Hearing complaint

1.4

13.3

630

4639

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

13.3

297

1875

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.6

13.3

116

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.6

13.3

116

RS230, ,

NOMESCO Finland

4.1

13.3

L04AX03

ATC

methotrexate; systemic

1.5

13.2

437

3010

K07

ICPC

Swollen ankles/oedema

1.8

13.2

214

1241

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

13.2

113

528

L95

ICPC

Osteoporosis

1.9

13.2

165

884

104

Kela drug reimbursment

Thyroid insufficiency

1.6

13.2

325

2101

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

13.1

1150

9286

BAA60

NOMESCO Finland

Total thyroidectomy

2.1

13.1

116

548

L16

ICPC

Ankle symptom/complaint

1.4

13.1

518

3693

M01AX17

ATC

nimesulide; oral

1.3

13.1

1092

8760

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.3

13.1

146

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

2.9

13.1

203

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

13.0

206

1185

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

13.0

109

504

UDC00

NOMESCO Finland

Ear microscopy

1.6

13.0

345

2266

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.9

13.0

174

952

I63.8

ICD-10 Finland

Other cerebral infarction

3.1

13.0

167

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.3

13.0

147

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

13.0

237

1421

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

12.9

176

969

K04.08

ICD-10 Finland

Other specified pulpit

1.6

12.9

318

2055

N06AG02

ATC

moclobemide; oral

1.8

12.9

191

1079

AN1

Coronary angiography

1.4

12.9

507

3613

XCW11

NOMESCO Finland

Assessment of strabismus

50.1

12.8

K80

ICPC

Cardiac arrhythmia NOS

1.5

12.8

365

2436

N02CC04

ATC

rizatriptan; oral

1.7

12.8

230

1373

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

5.3

12.8

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

12.7

245

1489

J20

ICD-10 Finland

Acute bronchitis

1.5

12.7

450

3141

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

12.7

225

1337

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.8

12.6

170

932

A10AE04

ATC

insulin glargine; parenteral

1.5

12.6

435

3021

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.7

12.6

106

CAC44

NOMESCO Finland

Combined decompression of orbit

70.0

12.6

UJH02

NOMESCO Finland

Anoscopy

1.8

12.6

184

1035

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

5.5

12.6

R01AD58

ATC

fluticasone, combinations; nasal

1.3

12.6

1070

8603

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

12.6

284

1798

H16.0

ICD-10 Finland

Corneal ulcer

1.7

12.6

213

1251

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

12.5

422

2917

S01EC01

ATC

acetazolamide; systemic

2.2

12.5

100

454

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.7

12.5

253

F01

ICPC

Eye pain

2.0

12.5

132

667

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

12.5

277

1745

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

12.5

801

6188

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

523

197

29.11

307.65

1.1

4.39

14.97

nmol/l

0.61

118

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2680

13824

2.76

301.52

2.8

2.1

196.57

223.10

u/l

0.20

2580

12925

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

161

25.85

231.46

1.0

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1588

7082

2.72

226.11

2.3

2.1

29.54

29.94

1.75

1535

6860

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

488

1052

4.98

212.78

1.4

1.3

576.28

521.57

mg/l

0.72

468

995

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

442

926

5.09

199.04

1.3

3.65

3.80

mmol/l

1.89

414

872

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

249

288

8.99

198.35

1.2

1.1

58.96

41.00

mg/l

0.98

207

235

(3013826) Glucose [Moles/volume] in Serum or Plasma

3944

27525

2.39

197.00

6.5

4.6

6.63

6.74

mmol/l

2.62

3787

25694

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

430

922

4.96

188.25

1.4

15.99

26.49

e6/l

0.65

339

709

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

240

283

8.81

188.23

1.1

339.01

277.71

mg/l

0.56

213

236

(3044290) Cell count panel - Cerebral spinal fluid

410

846

5.14

187.72

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

429

923

4.94

187.03

1.5

2235.37

5078.03

e6/l

0.30

353

755

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

230

263

9.07

184.77

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

197

201

10.11

172.30

1.1

1.02

1.15

u/l

1.69

100

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

252

355

7.38

169.99

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

201

216

9.61

169.22

1.7

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3261

21836

2.14

168.24

16.3

15.3

1.25

1.28

inr

0.86

957

6403

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

266

418

6.62

162.07

1.1

—

4.47

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3372

23375

2.08

152.27

8.3

6.6

1.21

mmol/l

0.43

2961

19810

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3114

21169

2.03

145.96

7.3

5.9

1.21

mmol/l

0.91

2914

19305

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

762

3007

2.77

131.57

2.5

2.4

24.55

22.53

au/ml

0.15

232

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2640

17617

1.92

123.17

4.6

3.6

25.43

79.10

ng/l

1.38

1863

12139

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

694

2749

2.73

118.33

1.4

1.3

51.00

55.02

au/ml

0.13

162

(3013707) Erythrocyte sedimentation rate by Westergren method

4349

34701

2.05

114.19

5.1

4.0

11.90

12.33

mm/h

1.18

4105

32050

(40760892) CBC W Ordered Manual Differential panel - Blood

3070

21982

1.85

110.63

8.3

6.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2881

20237

1.85

110.32

5.3

4.8

35.46

35.39

g/l

0.27

2704

18794

(3023410) Appearance of Cerebral spinal fluid

214

401

5.50

108.59

1.5

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3295

24298

1.84

106.07

6.9

6.2

11.17

11.54

umol/l

0.78

3129

23065

(3001604) Monocytes [#/volume] in Blood

3193

23360

1.83

105.08

7.9

5.8

0.60

0.59

e9/l

0.67

2805

20159

(3006315) Basophils [#/volume] in Blood

3196

23414

1.83

104.43

7.9

5.8

0.04

e9/l

0.39

2805

20193

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4437

36098

2.01

103.98

9.2

7.5

79.01

78.21

u/l

0.52

4230

34011

(3013115) Eosinophils [#/volume] in Blood

3271

24214

1.82

102.41

8.2

6.0

0.19

e9/l

0.01

2905

21214

(3033658) Prothrombin time (PT) actual/Normal

1886

11846

1.88

100.73

4.9

4.0

90.31

89.35

0.89

1849

11554

(3016018) Differential panel - Cerebral spinal fluid

212

429

5.09

98.65

1.4

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3954

31190

1.86

98.65

6.3

4.4

954.19

1707.59

e6/l

0.87

433

(3019198) Lymphocytes [#/volume] in Blood

3232

24037

1.79

97.58

8.0

5.8

1.88

1.91

e9/l

0.28

2881

21235

(3018418) pH of Serum or Plasma

2113

13903

1.82

96.21

4.5

4.0

7.40

0.00

376

2703

(3013650) Neutrophils [#/volume] in Blood by Automated count

3527

27099

1.78

93.35

11.3

8.9

4.14

4.13

e9/l

0.14

3145

23623

(3022096) Basophils/100 leukocytes in Blood

2913

21229

1.76

92.28

8.1

6.0

0.68

0.67

0.24

2774

19774

(3006504) Eosinophils/100 leukocytes in Blood

2986

21921

1.76

92.12

8.1

6.0

2.86

2.85

0.15

2847

20460

(3019069) Monocytes/100 leukocytes in Blood

2993

22065

1.75

90.25

8.4

6.3

8.70

8.62

0.71

2856

20630

(3005719) IgG [Mass/volume] in Serum or Plasma

742

3439

2.33

89.32

2.6

2.7

10.10

10.54

g/l

2.35

687

3134

(3037467) Urinalysis macro (dipstick) panel - Urine

4035

32521

1.81

87.94

5.8

4.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

3039

22667

1.73

86.35

8.2

6.1

27.03

27.66

2.49

2906

21233

(3018010) Neutrophils/100 leukocytes in Blood

3001

22331

1.72

85.78

8.0

5.9

57.83

57.45

1.00

2867

20905

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1481

9001

1.87

85.08

4.8

3.7

316.14

509.39

ng/l

0.86

1117

7075

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4322

35836

1.84

82.49

5.1

3.9

14.76

14.79

pmol/l

0.32

3989

32544

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2641

19226

1.69

79.73

2.2

2.0

94.63

95.11

pmol/l

0.20

1394

10051

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4947

43098

2.08

78.39

6.2

4.7

1.85

2.04

mu/l

2.62

4625

39457

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5268

47066

2.48

78.22

21.7

14.2

22.08

24.09

mg/l

4.83

4471

37382

(3023368) Bacteria identified in Blood by Culture

1910

12858

1.73

76.05

5.2

4.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

164

335

5.01

75.44

1.3

1.91

2.09

mmol/l

1.62

149

318

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

465

1877

2.61

75.12

1.8

1.9

38.00

38.86

u/l

0.44

427

1662

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1589

10194

1.77

74.76

2.1

1.7

1.10

1.23

mg/l

1.01

1215

7807

(3019550) Sodium [Moles/volume] in Serum or Plasma

5345

48288

2.59

73.50

24.6

16.3

139.66

139.65

mmol/l

0.07

5277

47061

(3023103) Potassium [Moles/volume] in Serum or Plasma

5350

48426

2.58

71.94

24.8

16.4

3.96

3.97

mmol/l

2.81

5268

47114

(3026008) Bacteria identified in Urine by Culture

2078

14507

1.68

71.15

3.9

3.1

—

(3018095) Leukocytes [#/volume] in Urine

2328

16739

1.66

71.09

5.0

3.7

87.85

103.49

e6/l

0.25

1732

11839

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1254

7613

1.83

70.38

2.1

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1936

13305

1.69

70.12

3.3

3.0

1170.58

1481.87

ng/l

2.88

1668

11427

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2091

14688

1.67

69.50

3.3

2.5

53.17

65.14

u/l

1.51

1927

13573

(36304419) Bacteria [Presence] in Urine

1871

12793

1.69

68.78

3.9

3.1

—

(3002582) Erythrocytes [#/volume] in Urine

2052

14381

1.66

68.58

4.3

3.2

71.68

80.51

e6/l

0.11

1629

11042

(3030467) Casts [#/volume] in Urine by Automated count

1908

13177

1.67

67.16

4.1

3.1

0.37

0.44

e6/l

0.65

1510

10030

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1239

7616

1.80

66.21

3.8

3.3

0.82

mmol/l

0.74

1170

7122

(3015377) Calcium [Moles/volume] in Serum or Plasma

2188

15723

1.63

65.42

3.2

3.4

2.34

2.35

mmol/l

2.70

1890

13781

(3003396) Base excess in Arterial blood by calculation

947

5371

1.91

65.34

8.1

7.1

1.19

1.12

mmol/l

0.23

763

4212

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

948

5383

1.91

65.16

8.0

7.1

5.12

5.09

kpa

0.38

899

5135

(3027801) Oxygen [Partial pressure] in Arterial blood

947

5382

1.91

64.90

8.0

7.1

12.29

12.33

kpa

0.08

903

5133

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

13.31

61.33

3.2

2.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

769

4171

1.97

60.19

2.4

2.2

360.11

374.86

nmol/l

1.21

713

3818

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1263

7999

1.74

60.12

3.5

2.7

1.22

1.12

e6/l

0.28

734

4550

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

305

1111

2.84

59.96

2.7

1.8

4.05

4.60

iu/l

0.40

135

402

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

908

5220

1.88

59.63

1.9

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

164

406

4.13

59.33

1.6

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

1031

6179

1.82

59.19

1.4

1.3

409.37

545.70

titre

2.06

222

1301

(3000850) Epithelial cells [#/volume] in Urine

1506

10050

1.68

58.94

3.2

2.6

5.57

5.54

e6/l

0.04

1367

9016

(3021960) Folate [Moles/volume] in Serum or Plasma

1603

10883

1.66

58.64

1.6

1.5

19.52

20.26

nmol/l

1.27

1392

9300

(3015736) pH of Urine

2453

18562

1.56

56.41

4.3

3.3

5.99

5.84

1.05

120

1330

(3016502) Oxygen saturation in Arterial blood

841

4822

1.87

55.37

8.5

7.5

95.64

95.70

0.10

811

4641

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2076

15200

1.57

54.71

3.8

3.2

31.62

35.81

u/l

1.80

1977

14396

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2503

19152

1.54

53.97

2.6

2.2

75.88

77.52

nmol/l

2.13

2295

17164

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

891

5241

1.83

53.94

2.0

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

2919

23137

1.53

53.24

4.6

3.6

0.00

estimate

0.28

579

4638

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3684

30757

1.55

52.62

4.1

3.1

52.64

48.66

u/l

1.33

3494

28577

(3019309) Folate [Moles/volume] in Red Blood Cells

1325

8769

1.66

52.59

1.8

1.7

1115.20

1174.53

nmol/l

1.57

1051

6616

(3021601) Nitrite [Presence] in Urine by Test strip

2906

23084

1.53

51.96

6.2

4.8

0.00

estimate

0.80

553

4375

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

107

210

5.17

51.55

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

2931

23349

1.52

51.54

4.7

3.6

0.02

0.00

estimate

1.08

541

4254

(3026782) Osmolality of Urine

1412

9565

1.63

50.86

3.4

2.9

548.64

543.17

mosm/kgh2o

0.40

1236

8229

(3007164) IgA [Mass/volume] in Serum or Plasma

1318

8802

1.65

50.14

1.6

1.5

2.37

2.45

g/l

0.71

804

5363

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1156

7479

1.68

49.67

3.7

2.9

3.79

2.48

e6/l

2.70

625

4068

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

12.80

48.58

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

149

5.91

48.55

1.2

1.1

2359.88

255.50

ng/l

1.13

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2577

20194

1.50

47.59

3.2

2.8

130.87

127.88

ug/l

0.20

2385

18684

(3002173) Hemoglobin [Mass/volume] in Arterial blood

764

4443

1.83

47.57

9.2

7.9

122.13

121.34

g/l

0.51

743

4319

(40758558) Short blood count panel - Blood

1656

11845

1.56

46.65

7.8

6.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

970

6099

1.71

45.98

6.4

5.9

1.02

1.04

mmol/l

1.22

910

5676

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1658

11971

1.54

44.33

2.5

2.2

2.92

2.96

mg/l

0.24

1450

10239

(3021589) Normoblasts [#/volume] in Blood

2616

20761

1.48

44.20

11.9

9.6

0.00

e9/l

1.85

2184

16944

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2759

22138

1.47

44.01

3.1

2.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1121

7413

1.64

43.55

2.5

12.81

13.01

umol/l

0.41

1046

6922

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

175

563

3.17

42.80

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.42

42.34

1.2

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

873

5449

1.71

42.20

2.0

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1426

10049

1.56

42.15

1.3

2.01

1.88

u/ml

0.08

371

2661

(3011397) Hemoglobin [Presence] in Urine by Test strip

1526

10936

1.54

41.74

4.7

3.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

4.64

41.69

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4748

42815

1.64

41.61

6.7

5.7

40.29

39.80

mmol/mol

2.75

4430

39574

(3044640) Blood type and Crossmatch panel - Blood

1980

14994

1.49

41.58

2.9

2.4

—

(3000991) Gas panel - Venous blood

667

3873

1.82

41.40

10.4

8.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

509

2713

1.96

41.18

2.1

1.8

1.25

1.37

g/l

0.50

477

2468

(40761511) CBC panel - Blood by Automated count

5264

48924

1.93

40.52

19.6

13.4

—

(3012544) pH of Venous blood

745

4505

1.75

40.21

4.9

3.7

7.38

7.37

—

(3002032) Base excess in Venous blood by calculation

722

4336

1.76

39.90

4.9

3.7

1.82

1.97

mmol/l

0.63

617

3670

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

519

2815

1.93

39.84

3.8

3.2

4.45

4.46

pmol/l

0.07

472

2500

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

309

1380

2.31

39.60

1.6

1.19

1.18

g/l

0.24

299

1301

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

678

4010

1.78

39.47

3.0

2.3

7.63

7.49

ug/l

0.05

596

3500

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

300

1333

2.32

38.91

1.7

0.23

0.24

g/l

1.08

288

1258

(3014111) Lactate [Moles/volume] in Serum or Plasma

686

4093

1.77

38.71

9.1

6.7

1.31

1.36

mmol/l

0.69

669

3989

(3021447) Carbon dioxide [Partial pressure] in Venous blood

719

4351

1.75

38.61

5.0

3.7

5.83

5.84

kpa

0.07

693

4225

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

224

4.39

38.50

1.1

—

(3036489) Thrombin time

351

1685

2.15

37.70

2.4

2.1

21.10

21.62

0.51

309

1468

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5339

50049

1.98

37.14

14.4

10.3

26.13

26.15

u/l

0.02

5199

48216

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

210

4.44

37.07

1.2

1.3

62.33

63.38

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

585

3375

1.82

36.89

1.8

1.6

—

(3044889) 12 lead EKG panel

3778

32772

1.45

36.59

4.5

3.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

651

3893

1.76

36.33

2.4

2.5

66.20

66.29

g/l

0.11

599

3537

(3014148) Varicella zoster virus Ab [Titer] in Serum

157

524

3.05

36.10

1.2

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1020

6866

1.59

36.07

2.6

2.5

2.35

2.32

g/l

0.74

948

6353

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4835

44200

1.60

35.44

19.2

13.3

81.69

80.78

ml/min/173m2

2.11

4198

36407

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

452

2435

1.93

35.29

10.7

9.1

24.64

24.29

mmol/l

1.48

435

2367

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4932

45333

1.63

34.99

5.2

4.5

5.98

5.94

mmol/l

1.13

4571

41258

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

956

6408

1.59

34.25

2.6

21.92

22.78

1.11

807

5460

(3009445) Proteinase 3 Ab [Units/volume] in Serum

382

1969

2.01

33.87

1.7

1.5

13.22

15.88

u/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1532

11391

1.47

33.72

2.9

2.3

—

(3019060) Gas panel - Arterial blood

539

3142

1.79

32.69

4.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1111

7782

1.53

32.56

1.3

27.10

31.94

iu/ml

0.61

314

2457

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

260

1173

2.27

32.51

1.7

2.0

12.46

11.23

mg/l

0.31

245

1087

(3024354) Oxygen [Partial pressure] in Venous blood

591

3564

1.73

31.82

4.6

3.1

4.69

4.59

kpa

0.55

568

3449

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

317

1571

2.08

31.28

2.8

2.3

250.20

634.01

ug/l

2.13

295

1479

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1196

8578

1.50

31.15

2.9

3.1

2.44

2.45

mmol/l

1.70

1024

7489

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

573

3460

1.73

30.67

3.7

3.8

91.02

91.15

ng/l

0.01

507

2962

(3015171) Extractable nuclear Ab [Units/volume] in Serum

344

1771

2.00

30.56

1.2

0.36

1.13

u/ml

1.90

172

(3020779) Urea [Moles/volume] in Serum or Plasma

672

4240

1.66

30.52

7.5

7.3

8.77

9.99

mmol/l

4.77

639

4048

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

479

2752

1.81

30.43

1.9

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

510

2987

1.78

30.37

7.3

7.0

24.67

24.57

mmol/l

0.25

485

2839

(3042936) Bacteria identified in Isolate by Culture

967

6663

1.54

30.34

2.4

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1361

10064

1.46

30.26

1.7

26562942.91

31028734.35

pmol/l

0.10

1152

8373

(3002385) Erythrocyte distribution width [Ratio]

4467

40546

1.46

29.77

25.3

16.8

15.02

15.06

0.10

4425

39813

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

806

5356

1.59

29.60

4.1

4.2

239.43

243.09

u/l

0.30

762

5055

(3009466) Valproate [Moles/volume] in Serum or Plasma

164

625

2.67

29.56

5.2

5.1

373.48

358.55

umol/l

0.59

141

546

(3004588) Protein electrophoresis panel - Serum or Plasma

533

3194

1.74

29.26

2.2

2.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

447

2551

1.82

29.00

10.4

9.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

798

5330

1.58

28.60

2.9

2.8

8.75

8.57

umol/l

0.07

685

4634

(3009508) Creatinine [Moles/volume] in Urine

1868

14744

1.40

28.57

3.6

3.2

7.49

7.58

mmol/l

0.34

1574

12434

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

675

4334

1.63

28.52

2.9

2.4

32.68

49.90

u/l

0.88

575

3704

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

4.89

28.28

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

5470

52285

2.01

27.17

32.2

20.9

39.83

40.27

2.11

5124

48882

(3007461) Platelets [#/volume] in Blood

5472

52319

2.02

27.03

31.9

20.8

250.17

250.22

e9/l

0.02

5392

50970

(3010813) Leukocytes [#/volume] in Blood

5474

52351

2.02

26.92

31.9

20.8

6.88

6.75

e9/l

3.28

5376

50827

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3358

29254

1.36

26.89

3.4

2.9

—

(3035941) MCH [Entitic mass]

5473

52343

2.01

26.84

31.7

20.7

30.27

30.31

1.17

5430

51574

(3024731) MCV [Entitic volume]

5473

52344

2.01

26.82

31.7

20.7

91.02

91.03

0.04

5431

51574

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

278

1391

2.05

26.72

1.7

1.5

39.30

7.62

iu/ml

0.45

289

(3026361) Erythrocytes [#/volume] in Blood

5473

52351

2.01

26.70

31.9

20.8

4.46

4.49

e12/l

2.90

5372

50840

(3000963) Hemoglobin [Mass/volume] in Blood

5473

52365

2.00

26.46

32.1

20.9

134.09

135.14

g/l

6.22

5429

51598

(3019150) Specific gravity of Urine by Refractometry

1345

10137

1.43

26.43

5.4

4.0

1.02

kg/l

0.82

191

1542

(3017143) Hepatitis C virus Ab [Presence] in Serum

771

5198

1.56

26.38

1.7

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1104

8025

1.47

26.33

1.9

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

464

2775

1.73

25.56

1.6

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

296

1544

1.97

25.31

1.6

346.67

322.94

titre

0.04

(3013512) EKG study

1720

13621

1.38

25.01

4.7

3.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

250

1239

2.06

24.66

1.5

1.4

26.82

14.50

iu/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4754

44104

1.46

24.36

4.4

3.9

1.31

1.29

mmol/l

0.62

4384

40300

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

392

2265

1.78

24.33

4.8

3.9

24.19

24.17

mmol/l

0.05

383

2219

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

253

1282

2.02

23.49

3.0

2.5

179.43

192.58

1.55

239

1219

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

162

686

2.40

23.49

1.3

1.2

6.71

3.38

u/ml

0.87

225

(3011412) CD3 cells [#/volume] in Blood

118

430

2.78

23.26

2.7

2.4

1.25

1.16

e9/l

0.70

107

390

(3048689) Calprotectin [Mass/mass] in Stool

792

5512

1.51

23.20

2.3

172.58

138.78

ug/g

0.51

635

4362

(3027945) Reticulocytes/100 erythrocytes in Blood

768

5317

1.51

23.06

2.6

2.5

1.79

1.77

0.12

668

4707

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2155

17844

1.33

22.88

5.1

3.8

—

(3012516) Albumin [Mass/volume] in Urine

1717

13765

1.35

22.59

3.4

3.3

777.35

357.60

mg/l

1.88

1090

8829

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

269

1415

1.95

22.45

2.6

2.2

95.15

91.45

1.97

256

1367

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

278

3.20

22.33

3.1

2.7

0.20

0.21

e9/l

0.21

245

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1004

7377

1.44

22.20

1.3

1.2

11.69

12.34

u/ml

0.09

355

2868

(3029937) Albumin [Presence] in Urine by Test strip

1580

12532

1.36

22.20

5.4

4.0

0.00

estimate

1.54

544

4208

(3004119) Hemoglobin [Mass/volume] in Venous blood

457

2828

1.67

22.12

4.8

3.1

130.33

129.20

g/l

0.52

441

2753

(3021387) Prolactin [Units/volume] in Serum or Plasma

273

1455

1.92

21.92

1.9

1.6

413.16

300.47

mu/l

0.50

245

1330

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

4.71

21.91

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

342

1963

1.79

21.69

5.1

5.3

1.76

1.65

0.69

320

1837

(40768797) Stomach Pathology biopsy report

884

6368

1.46

21.68

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

289

3.11

21.58

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

552

3604

1.59

21.51

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

178

3.74

21.37

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

292

3.08

21.22

3.0

2.6

480.94

537.22

e6/l

0.54

248

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4984

46924

1.48

21.15

5.6

4.8

2.64

2.74

mmol/l

12.43

4657

43217

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

198

961

2.10

20.69

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

198

961

2.10

20.69

1.4

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

259

1383

1.91

20.68

1.9

1.8

—

(40761535) Cells panel - Urine sediment

582

3896

1.55

20.29

4.7

3.4

—

(3000060) B lymphocytes [#/volume] in Blood

106

4.56

20.27

2.5

2.2

1790.00

347.86

e6/l

0.39

(3028707) Methadone [Presence] in Urine by Screen method

156

694

2.28

20.25

4.5

3.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4865

45673

1.43

20.20

5.0

4.3

1.42

1.46

mmol/l

9.07

4523

42063

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

600

4048

1.54

20.19

3.4

2.9

175.96

202.77

ng/l

0.88

539

3676

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

136

4.07

20.10

1.3

1.2

13.20

22.11

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1777

14512

1.33

20.09

4.0

3.8

9.41

9.44

mg/mmol

0.01

1115

9234

(3025941) Bacteria identified in Stool by Culture

415

2570

1.66

20.00

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4894

46012

1.44

20.00

5.0

4.3

4.50

4.64

mmol/l

19.57

4582

42604

(3000494) Fungus identified in Specimen by Culture

763

5429

1.47

19.82

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

2266

19164

1.30

19.77

2.2

2.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

151

670

2.29

19.73

1.3

1.2

4.54

4.47

u/ml

0.02

285

(3047181) Lactate [Moles/volume] in Blood

274

1518

1.85

19.52

5.6

6.3

1.24

1.30

mmol/l

0.51

246

1339

(3007930) Methemoglobin/Hemoglobin.total in Blood

331

1944

1.75

19.39

5.3

0.89

0.02

311

1823

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

757

5416

1.46

19.06

2.0

1.8

1.55

1.48

2.20

648

4772

(3005322) IgE [Units/volume] in Serum or Plasma

435

2760

1.62

19.04

1.4

1.3

309.66

212.73

u/ml

0.67

404

2541

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

249

1350

1.88

19.00

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

112

4.31

18.94

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

273

1542

1.81

18.28

2.6

2.2

1751.92

5453.68

u/l

3.04

608

(3021879) Hepatitis B virus core Ab [Presence] in Serum

504

3367

1.54

17.66

1.5

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

159

3.61

17.63

2.8

2.1

9.74

10.60

0.12

149

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

261

1475

1.81

17.45

2.9

3.3

39.62

56.28

mg/l

0.71

216

1193

(3022145) Colonoscopy Study observation

715

5143

1.45

17.41

1.4

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.78

17.39

1.9

2.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1505

12206

1.32

17.35

1.8

1.6

1.41

1.37

mmol/l

0.81

1286

10227

(3026493) Urate [Moles/volume] in Serum or Plasma

1517

12333

1.31

17.15

3.0

2.7

4323.54

4639.70

umol/l

0.11

1326

10803

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

304

1806

1.72

17.11

2.0

2.2

3.48

3.67

g/l

2.11

277

1637

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

304

1806

1.72

17.11

2.0

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

222

3.13

17.07

1.5

1.3

129.91

134.07

nmol/l

0.22

222

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

897

6739

1.39

17.06

1.7

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

304

1808

1.72

17.04

2.0

2.2

7.30

7.45

g/l

0.88

277

1637

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

110

454

2.45

16.97

2.4

2.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

631

4458

1.47

16.86

2.3

0.22

0.21

g/l

1.52

578

4160

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

301

1795

1.71

16.71

1.1

6.03

1.23

u/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

268

1548

1.77

16.66

2.9

2.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

356

2221

1.64

16.65

4.8

3.3

25.18

25.28

mmol/l

0.25

342

2152

(3024869) Neuronal Ab [Presence] in Serum

4.89

16.59

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1686

1.73

16.55

2.0

2.2

2.84

2.97

g/l

1.27

259

1517

(3034860) Kappa light chains.free [Mass/volume] in Serum

258

1477

1.78

16.53

2.9

3.3

46.05

99.08

mg/l

0.76

215

1194

(3017181) Myelocytes/100 leukocytes in Blood

574

4000

1.48

16.43

4.8

4.2

0.95

0.92

0.10

213

1359

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

113

4.01

16.17

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

329

2.67

16.09

2.3

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

118

3.92

16.06

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

530

3655

1.50

15.96

4.6

4.0

0.54

0.70

1.49

183

1178

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

137

639

2.17

15.93

1.1

1.2

123.17

115.97

1.60

125

578

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

250

1436

1.77

15.85

2.8

3.2

5.58

2.44

ratio

0.38

124

(3023511) Choriogonadotropin [Units/volume] in Urine

154

758

2.06

15.58

1.5

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

279

1662

1.71

15.56

4.4

3.9

1.30

1.40

mmol/l

0.85

273

1637

(3000570) Elastase.pancreatic [Mass/mass] in Stool

235

1334

1.79

15.51

1.5

1.4

280.05

273.67

ug/g

0.19

138

763

(3023183) Ammonium ion [Moles/volume] in Plasma

189

1004

1.91

15.40

2.7

2.9

31.41

34.60

umol/l

1.13

171

910

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.81

15.40

1.9

2.0

21.12

15.69

umol/l

1.22

(3020191) Ethanol [Moles/volume] in Serum or Plasma

372

2.52

15.38

1.7

1.5

1.12

1.24

promille

0.31

288

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

296

1799

1.68

15.33

2.1

1.8

—

(3049717) Cytology report of Urine Cyto stain

293

1777

1.68

15.30

2.4

2.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

3.84

15.25

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

177

927

1.94

15.05

5.2

5.6

302.46

2234.60

iu/ml

0.58

129

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

224

1266

1.80

15.01

1.2

60.36

38.05

u/ml

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

1681

1.69

14.93

2.0

2.2

9.53

10.22

g/l

2.35

251

1498

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

12.43

14.83

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

454

3085

1.51

14.66

1.3

1.2

116.37

141.13

iu/ml

0.76

165

1146

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

377

2469

1.56

14.41

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

247

1454

1.73

14.40

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

443

3009

1.51

14.33

3.6

3.7

5.13

5.16

kpa

0.25

417

2858

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

101

3.98

14.29

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

116

531

2.21

14.18

1.7

1213.33

1128.00

titre

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

108

482

2.26

14.04

1.2

99.17

95.35

0.78

453

(3039000) Anion gap in Blood

193

1066

1.84

13.96

6.5

7.4

10.73

11.27

mmol/l

1.48

175

953

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

206

2.98

13.96

4.2

2.0

142.61

137.87

umol/l

0.05

111

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

232

1354

1.74

13.95

3.8

2.6

3.61

3.54

g/l

0.27

224

1283

(3018572) Chloride [Moles/volume] in Blood

193

1067

1.84

13.92

6.5

7.4

105.66

105.07

mmol/l

0.94

175

954

(3009343) pH of Capillary blood

436

2970

1.51

13.91

3.6

3.7

7.42

7.41

0.50

371

(3025159) Blasts/100 leukocytes in Blood

513

3611

1.46

13.90

4.8

4.2

0.11

0.34

0.92

149

978

(3021440) Promyelocytes/100 leukocytes in Blood

537

3819

1.45

13.78

4.9

4.2

0.10

0.11

0.13

175

1179

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

235

1382

1.73

13.76

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

238

1413

1.71

13.47

3.3

3.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

303

1917

1.61

13.42

2.1

1.9

1.72

2.51

ug/l

0.47

265

1691

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

190

3.02

13.36

1.1

1615.79

1495.34

miu/ml

0.29

190

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

273

2.66

13.32

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

118

559

2.13

13.26

1.6

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

215

1247

1.75

13.23

4.2

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

419

2867

1.50

13.08

3.5

3.6

1.63

1.84

mmol/l

0.60

303

2116

(3024980) IgG subclass 4 [Mass/volume] in Serum

142

725

1.98

13.05

1.9

1.6

0.92

0.79

g/l

0.48

102

551

(3023520) Reticulocytes [#/volume] in Blood

551

3984

1.42

12.90

2.4

2.6

69.43

69.41

e9/l

0.00

428

2998

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.60

12.87

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

164

886

1.88

12.76

1.3

1.2

66.67

251.25

titre

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

110

3.65

12.72

1.1

—

(3024928) Oxygen saturation in Venous blood

175

968

1.83

12.64

5.4

2.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1006

8017

1.31

12.63

1.7

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.76

12.58

1.1

1.2

—

(3019225) pH of Specimen

631

4692

1.39

12.55

5.0

4.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

716

1.96

12.47

2.4

2.8

710.63

1570.50

u/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

105

490

2.16

12.29

1.5

1.8

—

(4200892) Spirometry reversibility

459

3239

1.45

12.26

1.5

1.4

—

(3011288) Drugs identified in Urine by Screen method

190

1088

1.77

12.24

6.3

3.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

132

673

1.98

12.21

1.1

—

(3036180) Methadone [Presence] in Urine

186

2.92

11.99

7.3

3.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

361

2.35

11.98

1.2

—

(3042517) Benzodiazepines panel - Urine

5.66

11.93

3.0

2.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

146

777

1.90

11.92

1.6

1.9

4.88

4.92

mmol/24h

0.04

133

680

(3020891) Body temperature

292

1885

1.58

11.91

5.6

4.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

228

1386

1.67

11.86

1.4

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

199

1171

1.72

11.68

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

245

2.63

11.67

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

147

3.15

11.62

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

222

1351

1.67

11.51

2.1

0.05

0.03

g/l

0.27

204

1239

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.52

11.40

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

165

927

1.80

11.36

1.2

50.76

41.66

u/ml

0.27

105

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

181

1046

1.75

11.33

2.7

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

190

1115

1.73

11.27

2.9

3.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

372

2.28

11.20

2.1

2.3

42.56

38.78

1.36

363

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.91

11.19

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1473

12502

1.24

10.80

4.1

3.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

102

496

2.08

10.79

1.2

1.1

1.48

2.53

iu/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

253

1619

1.59

10.74

3.0

0.31

0.33

u/ml

0.72

145

946

(3024666) Lithium [Moles/volume] in Serum or Plasma

244

2.56

10.72

14.9

11.8

0.62

mmol/l

0.05

228

(3016879) Cocaine [Presence] in Urine

235

1481

1.61

10.63

4.1

2.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

151

3.00

10.50

3.5

2.6

30.99

29.08

umol/l

0.22

108

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

248

2.52

10.38

3.3

2.6

43.43

40.54

0.49

140

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

454

2.09

10.15

1.6

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

194

1180

1.67

10.12

1.3

3.70

6.44

u/ml

0.78

197

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

192

1165

1.67

10.11

1.3

1.2

7.19

5.58

u/ml

0.11

123

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

293

1968

1.52

10.03

2.3

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

239

1535

1.58

10.01

2.3

0.57

0.95

g/l

1.56

210

1326

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

639

4928

1.33

9.99

3.9

3.4

—

(3000764) Benzodiazepines [Presence] in Urine

246

1594

1.57

9.92

4.0

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

135

745

1.83

9.91

1.3

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

236

2.52

9.90

1.3

1.2

161.26

342.52

u/l

2.26

217

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

163

956

1.73

9.74

1.2

1.16

4.87

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

159

928

1.73

9.67

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

194

1197

1.64

9.59

1.4

11.92

10.30

u/l

0.67

156

985

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

115

611

1.90

9.52

8.0

6.4

11.67

11.73

mg/l

0.05

103

561

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

144

2.93

9.47

1.0

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

182

1110

1.66

9.42

3.2

3.1

8.62

8.13

kpa

3.15

177

1083

(3028192) IgG subclass 2 [Mass/volume] in Serum

455

2.04

9.36

1.8

1.3

3.12

2.92

g/l

0.39

319

(3024139) IgG subclass 3 [Mass/volume] in Serum

455

2.04

9.36

1.8

1.3

0.39

0.41

g/l

0.25

320

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

313

2164

1.47

9.32

1.6

1.7

1.61

1.55

g/l

0.55

263

1864

(3027135) IgG subclass 1 [Mass/volume] in Serum

456

2.03

9.31

1.8

1.3

6.00

6.97

g/l

1.95

319

(3027944) Amphetamines [Presence] in Urine

241

1578

1.55

9.30

4.0

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

521

3941

1.35

9.26

3.9

1.22

1.23

mmol/l

2.47

475

3449

(3037756) Immunofixation for Serum or Plasma

161

957

1.70

9.19

1.4

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

217

1395

1.58

9.08

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1403

1.58

9.08

2.1

2.0

37.85

37.58

g/l

0.28

190

1231

(3028300) Cannabinoids [Presence] in Urine

244

1611

1.54

9.08

4.0

2.2

—

(3027008) Opiates [Presence] in Urine

243

1605

1.54

9.03

3.1

2.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1256

1.61

9.00

2.2

2.1

0.00

g/l

-0.00

182

1148

(3003181) Sodium [Moles/volume] in Urine

141

813

1.75

8.98

1.5

1.3

70.29

63.05

mmol/l

1.06

120

652

(3003338) MCHC [Mass/volume]

4212

39894

1.21

8.98

28.8

18.1

331.76

332.32

g/l

3.72

4186

39583

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

155

923

1.70

8.81

1.5

1.4

—

(4062490) Immunoglobulin typing, IgG

459

2.00

8.79

1.9

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

204

1306

1.58

8.71

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

156

935

1.69

8.66

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

195

1239

1.59

8.60

2.2

2.1

0.00

g/l

-0.00

182

1147

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

259

2.33

8.59

1.4

1.5

4.93

6.81

u/l

1.69

222

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

724

5798

1.28

8.55

9.5

7.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

148

878

1.70

8.54

1.2

282.15

273.46

u/ml

0.13

543

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

105

563

1.88

8.50

1.4

1.3

—

nmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

201

1295

1.57

8.36

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

556

4312

1.32

8.34

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

611

4802

1.30

8.32

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

193

1234

1.58

8.30

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

203

1315

1.56

8.25

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

183

1157

1.60

8.25

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1759

15522

1.19

8.24

5.0

3.24

3.61

ug/l

0.15

1558

13927

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

104

564

1.86

8.15

1.4

1.3

—

(3051651) Icteric interference index of Serum or Plasma

273

2.25

8.05

3.5

3.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

187

2.53

8.04

1.7

2.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

503

1.90

8.01

1.7

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

268

1854

1.47

8.00

3.9

24.62

24.88

mmol/l

0.89

241

1706

(3028433) Virus identified in Specimen by Culture

153

2.69

7.97

1.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

170

1066

1.61

7.95

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

143

860

1.68

7.88

1.7

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

132

2.81

7.83

3.4

3.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

281

3936

0.70

7.79

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.05

7.79

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1425

16266

0.84

7.76

3.3

2.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

197

1292

1.54

7.61

1.2

96.92

120.49

titre

0.30

102

(3051611) Lipemic interference index of Serum or Plasma

477

1.90

7.59

3.3

3.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

340

2.07

7.56

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

340

2.07

7.56

1.1

1.2

—

(3022313) Gas panel - Capillary blood

300

2145

1.42

7.52

3.9

3.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

341

2.07

7.50

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

341

2.07

7.50

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

341

2.07

7.50

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

212

2.37

7.50

1.1

16.60

24.59

u/ml

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

342

2.06

7.44

1.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

276

2.19

7.44

1.1

14.38

11.36

iu/ml

0.20

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

137

828

1.67

7.43

1.4

119.45

114.29

u/ml

0.24

176

(3013139) Helicobacter pylori Ag [Presence] in Stool

403

3035

1.35

7.39

1.2

—

(3045414) Leukocytes [Presence] in Urine

299

2148

1.41

7.31

1.9

—

(3008898) HLA-B27 [Presence]

224

1524

1.49

7.30

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

439

3357

1.33

7.27

2.4

2.1

12.13

12.46

nmol/l

0.35

393

2976

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

106

603

1.77

7.16

1.4

25.93

27.06

u/l

0.13

491

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

268

2.18

7.13

1.4

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

199

2.37

7.09

1.5

1.6

5.84

7.51

nmol/l

0.15

162

(3011985) Renin [Units/volume] in Plasma

106

611

1.75

6.86

1.9

1.4

73.71

53.38

mu/l

0.44

539

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

297

2156

1.40

6.85

2.0

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

101

575

1.77

6.82

1.5

1.3

338.19

300.82

pmol/l

0.46

490

(3029634) Reagin Ab [Titer] in Serum by VDRL

107

621

1.74

6.77

1.9

2.0

4.00

2.25

titre

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

248

2.19

6.76

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

276

2.11

6.65

1.1

1.2

—

(3000492) Spirometry study

560

4483

1.28

6.61

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

278

2.10

6.54

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

125

766

1.65

6.48

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

227

2.21

6.45

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

208

2.27

6.45

6.5

3.1

—

(3012501) Base excess in Blood by calculation

167

1099

1.54

6.42

3.6

4.3

2.07

2.60

mmol/l

2.33

117

748

(3037121) Protein [Mass/volume] in Urine

229

1609

1.44

6.37

3.4

3.1

0.29

0.30

g/l

0.07

101

663

(3026389) Candida sp identified in Specimen by Organism specific culture

110

655

1.69

6.37

1.5

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.06

6.34

1.2

1.87

1.72

umol/24h

0.31

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

144

919

1.58

6.34

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

262

2.11

6.31

1.1

1.05

ratio

0.09

(4035726) Immunohistochemistry procedure

524

4187

1.28

6.28

1.5

1.4

—

(3010421) pH of Blood

189

1284

1.49

6.26

3.5

4.1

7.42

0.17

175

1168

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

101

591

1.72

6.24

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

125

774

1.63

6.24

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

170

1131

1.52

6.22

1.7

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

150

972

1.56

6.19

3.9

3.7

57.55

57.83

0.10

150

972

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

103

608

1.71

6.17

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

355

2700

1.34

6.14

2.2

1.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

594

1.71

6.13

1.5

—

(3017704) Immunofixation for Urine

240

2.14

6.05

1.1

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

189

2.28

6.01

1.6

1.8

2.18

1.98

umol/l

0.73

178

(3025468) Yersinia sp identified in Specimen by Organism specific culture

100

590

1.71

6.01

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

101

598

1.70

5.99

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1404

12438

1.17

5.92

4.4

4.3

22.45

21.87

0.67

643

6130

(3008536) Aspergillus sp Ab [Presence] in Serum

2.90

5.87

1.7

2.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

410

1.84

5.85

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

100

596

1.69

5.81

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

164

1101

1.50

5.78

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

131

2.53

5.77

1.4

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.46

5.72

1.8

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.24

5.71

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

112

692

1.63

5.68

2.7

2.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

466

1.77

5.65

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

258

1895

1.38

5.61

1.4

29.47

28.11

iu/l

0.25

212

1628

(3021901) Oxygen saturation in Capillary blood

136

885

1.55

5.55

2.6

2.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

152

2.38

5.54

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.37

5.52

1.1

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

311

1.94

5.52

1.0

32.45

44.47

ng/l

2.43

209

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

298

1.96

5.47

1.2

1.3

0.31

0.87

u/ml

1.05

167

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

464

1.76

5.44

1.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

119

756

1.59

5.40

1.8

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

119

756

1.59

5.40

1.8

1.6

—

(40768443) Skin Pathology biopsy report

272

2028

1.36

5.40

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

102

624

1.65

5.39

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

155

1045

1.50

5.38

2.6

2.5

16.67

16.14

0.93

537

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

142

2.40

5.36

1.2

1.3

0.32

0.30

g/l

0.49

112

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.86

5.34

1.2

0.73

0.71

umol/24h

0.09

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

213

2.12

5.31

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

182

1271

1.45

5.29

2.8

2.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.72

5.29

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

309

1.92

5.28

1.0

722.48

733.32

ng/l

0.05

205

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

104

645

1.62

5.22

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

820

1.55

5.17

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1449

12985

1.16

5.16

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

101

625

1.63

5.13

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

164

2.26

5.13

1.0

1.1

—

(3002256) Pathology report gross observation

729

6174

1.21

5.13

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

120

775

1.56

5.10

4.5

3.5

1.38

1.66

0.38

104

687

(40757494) Bilirubin.total [Moles/volume] in Blood

258

1.99

5.06

2.0

2.4

21.74

22.03

umol/l

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

126

825

1.54

5.04

1.6

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.45

5.04

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.41

5.02

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

131

2.37

4.80

1.7

1.9

16.97

54.17

u/l

1.24

123

(21494755) Public health laboratory ask at order entry panel

324

4123

0.77

4.80

1.3

—

(3045424) Erythrocytes [Presence] in Urine

120

787

1.54

4.79

1.2

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

336

1.82

4.72

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

190

2604

0.72

4.72

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

175

1242

1.42

4.71

1.1

6.76

6.62

u/ml

0.01

148

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

680

5769

1.20

4.69

5.0

4.4

32.41

32.44

0.02

513

3925

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.68

4.67

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

121

2.40

4.62

1.2

1.4

116.52

136.23

nmol/l

0.32

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

302

2343

1.31

4.61

1.1

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.81

4.54

1.2

1.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

200

2.06

4.52

1.6

2.0

149.52

153.02

0.11

185

(3017732) Neutrophils [#/volume] in Blood

399

3217

1.26

4.49

3.2

3.0

5.41

5.11

e9/l

0.18

306

2604

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

114

752

1.53

4.46

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

466

3829

1.24

4.43

2.7

2.6

65.49

65.45

ml/min/173m2

0.01

199

1525

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

410

1.72

4.43

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

410

1.72

4.43

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

410

1.72

4.43

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

154

1082

1.43

4.40

2.1

2.2

128.69

128.45

g/l

0.04

113

783

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

315

1.82

4.39

1.1

1.0

—

(1002224) Polysomnography panel

235

1775

1.34

4.35

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

316

1.81

4.35

1.1

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

119

2.36

4.31

1.1

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

376

1.74

4.30

1.2

197.69

177.01

titre

0.08

(1616796) Gas panel - Central venous blood

155

1096

1.43

4.29

3.0

3.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.96

4.27

2.7

1.2

77.90

49.74

—

(3034426) Prothrombin time (PT)

158

2.16

4.26

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

240

1.92

4.24

1.5

1.3

1.20

1.21

nmol/l

0.00

185

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

454

1.66

4.22

4.0

3.6

—

(3051593) INR in Capillary blood by Coagulation assay

206

2.00

4.20

5.1

12.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

105

691

1.53

4.18

1.2

1.1

20.56

11.87

au/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

109

725

1.51

4.13

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

289

2270

1.29

4.06

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

202

1.99

4.05

1.2

1.3

182.70

161.72

mmol/24h

0.71

202

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

104

2.41

4.05

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

104

2.41

4.05

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

104

2.41

4.05

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

104

2.41

4.05

1.0

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

361

1.73

4.04

1.1

—

13.84

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.76

4.01

1.5

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

310

1.78

4.00

1.0

254.89

320.28

ng/l

1.81

212

(3019832) Treponema pallidum Ab [Presence] in Serum

483

4029

1.22

3.99

1.6

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

170

2.07

3.95

1.3

1.5

14.85

16.14

pmol/l

0.52

145

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

143

1014

1.42

3.93

1.6

1.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.79

3.86

3.3

1.2

12.33

42.69

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

119

819

1.46

3.84

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.97

3.84

1.0

1.1

0.01

0.30

u/ml

1.26

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

200

1.96

3.81

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

634

1.52

3.79

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

179

1329

1.36

3.76

1.4

1.3

182.58

219.92

miu/ml

0.82

610

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

12.01

3.76

1.0

1.2

1.87

1.18

mg/l

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

287

1.78

3.75

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

317

1.74

3.74

3.8

2.4

—

(3022621) pH of Urine by Test strip

382

3135

1.23

3.72

3.5

3.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

480

1.59

3.66

5.3

3.5

57.59

56.50

0.15

403

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

155

2.07

3.66

1.7

1.9

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

365

1.68

3.64

1.2

47.20

42.76

u/ml

—

(3016038) Potassium [Moles/volume] in Urine

313

1.73

3.61

1.2

29.78

35.85

mmol/l

1.26

273

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

111

764

1.46

3.61

1.3

39.74

44.24

u/l

0.08

663

(3025130) Human papilloma virus identified in Specimen

562

1.54

3.59

1.8

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

150

2.07

3.56

1.5

2.2

134885.71

21295.67

u/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

661

1.49

3.53

1.6

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

168

1250

1.35

3.51

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

10.01

3.49

1.3

2.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.61

3.46

1.7

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

103

707

1.47

3.42

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.35

3.40

1.1

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

181

1.94

3.37

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

451

1.58

3.37

3.3

2.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

573

4936

1.18

3.36

3.2

4.0

46.00

21.72

ug/l

0.48

467

3995

(3004616) Nuclear Ab [Presence] in Serum

565

1.51

3.31

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

477

1.56

3.31

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.92

3.29

1.0

—

(40761536) Microorganisms panel - Urine sediment

477

4053

1.19

3.28

4.8

3.9

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.58

3.26

1.3

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

122

873

1.41

3.25

2.2

1.8

195.75

201.30

pmol/l

0.24

117

818

(3008295) Osmolality of Serum or Plasma

487

1.55

3.25

1.6

1.5

281.90

278.77

mosm/kgh2o

0.54

382

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

286

1.72

3.23

1.6

4.89

7.02

u/l

0.64

234

(3043410) Blood group antigens tested for on Red Blood Cells

123

2.12

3.19

1.5

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

236

1.79

3.16

2.8

2.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

207

1.84

3.16

1.4

1.3

3.93

4.59

umol/l

0.58

193

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.80

3.08

1.0

—

(3006462) Nitrate [Presence] in Urine

231

1.78

3.07

3.8

3.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

791

7034

1.14

3.05

1.5

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.59

3.04

1.2

1.3

234.63

64.45

ng/l

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

520

1.51

3.03

1.8

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

520

1.51

3.03

1.8

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

521

1.50

3.00

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

457

1.54

2.99

1.3

1.2

53.73

63.19

u/l

0.92

416

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.29

2.99

4.4

5.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.85

2.97

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

120

2.09

2.97

1.2

1.1

—

(4146454) Self-monitoring of blood glucose

498

1.51

2.97

3.1

2.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.24

2.96

1.7

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

127

935

1.37

2.90

3.6

1.8

0.80

0.83

nmol/l

0.18

108

784

(3004451) EKG impression Narrative

228

1.76

2.90

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

305

1.64

2.85

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

504

1.49

2.82

2.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

298

1.65

2.82

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

239

1.72

2.76

1.7

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

239

1.72

2.76

1.7

2.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

557

1.46

2.73

1.3

1.6

53.95

59.66

0.53

353

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

579

5087

1.15

2.67

1.7

—

(3044927) Protein electrophoresis panel - Urine

454

1.50

2.66

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

528

1.46

2.65

1.6

—

(3019977) pH of Arterial blood

273

1.65

2.64

3.0

2.5

7.40

7.42

0.88

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

375

1.55

2.63

1.2

1.3

8.08

9.05

mmol/l

1.13

363

(3000330) Specific gravity of Urine by Test strip

291

2416

1.22

2.62

4.4

3.4

—

(3011648) Oxygen content in Venous blood

368

1.55

2.60

2.1

2.3

11.44

11.17

0.18

368

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

229

1.71

2.58

3.5

3.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

207

1.74

2.57

2.2

2.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

107

2.06

2.56

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

499

1.47

2.56

5.6

4.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

541

1.45

2.54

13.9

17.8

7.12

7.25

mmol/l

0.14

451

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.73

2.54

2.2

2.0

1.37

1.43

mg/l

0.04

(3033705) Calcium.ionized [Moles/volume] in Venous blood

566

1.44

2.54

3.5

2.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.23

2.51

3.4

8.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

428

1.50

2.51

1.6

1.3

1.71

1.51

nmol/l

0.66

384

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

278

1.62

2.48

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.20

2.47

1.7

1.6

187.28

133.52

ng/l

0.39

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

160

1251

1.29

2.46

3.6

1.53

1.55

mg/l

0.12

143

1141

(3006270) Folate [Moles/volume] in Blood

406

1.51

2.45

1.2

1.1

343.44

364.34

nmol/l

0.38

351

(3028717) Thiamine [Mass/volume] in Blood

2.67

2.45

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.46

2.44

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

117

1.97

2.40

1.0

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

328

1.56

2.39

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

426

1.48

2.36

1.2

1.5

26.31

29.76

0.27

266

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.12

2.36

1.9

3.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

160

1260

1.28

2.34

1.3

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

244

1.64

2.33

1.3

1.2

31.70

20.60

u/l

0.37

207

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

110

824

1.34

2.32

1.8

1.7

—

(3005570) Glucose [Moles/volume] in Urine

478

1.45

2.30

2.2

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

276

2314

1.20

2.29

3.3

3.4

60.86

61.09

u/ml

0.00

269

2222

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

4.62

2.27

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

142

1108

1.29

2.25

1.4

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

171

1.76

2.24

2.9

2.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

142

1.83

2.22

1.2

1.1

92.75

87.37

0.53

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

718

1.36

2.22

1.1

133.32

14300.52

iu/ml

0.53

164

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

240

1.63

2.21

1.2

1.1

16.97

27.65

u/l

1.43

219

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

256

1.61

2.20

1.4

1.2

91.86

84.72

u/l

0.17

221

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

107

1.97

2.20

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

143

1.82

2.18

4.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

143

1.82

2.18

4.0

2.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.34

2.18

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

527

1.41

2.15

2.0

2.4

0.83

1.45

g/24h

2.11

269

(40765096) Chromosome analysis panel by Banding

144

1.81

2.14

1.3

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

511

1.41

2.13

2.3

2.1

4.91

6.53

umol/l

1.39

371

(3035933) Granulocytes/100 leukocytes in Blood

137

1.83

2.13

3.5

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

152

1.78

2.11

1.4

1.3

152.93

122.99

nmol/24h

0.15

152

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

382

1.47

2.05

1.4

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

103

1.95

2.05

1.2

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.00

2.04

1.0

1.3

—

mmol/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

148

1846

0.80

2.02

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

120

935

1.29

1.97

3.2

3.1

0.75

0.82

nmol/l

1.66

712

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.55

1.94

1.2

303.48

370.90

nmol/l

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.75

1.93

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

970

8968

1.10

1.92

2.9

3.0

0.75

0.78

ug/l

0.26

670

6030

(40758292) HTLV I+II Ab panel - Serum

2.05

1.90

1.1

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

188

1.65

1.90

1.8

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

188

1.65

1.90

1.8

2.3

—

(3017569) Oxygen content in Arterial blood

235

1.58

1.89

1.7

2.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

203

1689

1.21

1.88

2.8

3.5

884.84

3324.42

u/ml

0.76

172

1437

(21494890) Protein electrophoresis panel - 24 hour Urine

482

1.39

1.87

2.5

2.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

308

1.50

1.87

1.4

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.86

1.86

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

190

1.64

1.83

1.9

2.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.27

1.80

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

191

1.63

1.80

2.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.57

1.80

1.7

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

1.70

1.79

1.6

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

140

1127

1.25

1.79

1.6

12566.32

12645.96

e6/l

0.01

108

807

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

420

1.41

1.77

2.9

4.8

212.98

70.18

u/ml

0.84

114

(3042631) Mycobacterium sp identified in Specimen

634

1.33

1.76

2.7

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

387

1.43

1.76

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

338

1.45

1.74

1.4

1.6

20.25

21.35

u/ml

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.73

1.0

1.2

8.33

19.89

u/l

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.22

1.73

1.2

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.92

1.72

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.88

1.70

1.2

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

133

1.73

1.69

1.1

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

156

1.67

1.68

1.4

2.1

9599.25

19361.98

e6/l

0.33

(3032773) Endomysium IgG Ab [Titer] in Serum

366

1.42

1.67

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.18

1.67

1.0

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

2.58

1.65

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

150

1.67

1.63

1.1

—

(3021788) Differential panel - Synovial fluid

106

837

1.27

1.62

1.4

1.6

—

(3014271) Vancomycin [Susceptibility]

237

1.52

1.62

2.8

2.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

158

1.65

1.62

1.3

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

221

1.54

1.61

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

221

1.54

1.61

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

128

1.72

1.60

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.33

1.58

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.69

1.58

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

630

1.31

1.55

1.1

1.52

g/l

0.01

568

(3023487) Leukocytes [#/volume] in Peritoneal fluid

176

1.59

1.54

1.6

2.4

5332.14

801.54

e6/l

0.44

126

(40768446) Kidney Pathology biopsy report

176

1.59

1.54

1.7

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.34

1.52

1.2

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

241

1.50

1.51

2.1

43.80

217.87

ug/min

—

(3048879) Bone marrow aspiration report

138

1.67

1.51

1.9

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.16

1.50

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.86

1.50

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

358

1.40

1.49

1.9

2.2

8.16

6.59

mmol/l

1.62

245

(3000012) Reticulocyte production index

680

1.28

1.47

1.9

2.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

981

0.77

1.46

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

445

1.35

1.46

1.3

1.4

226345.54

120711.71

e6/l

0.30

310

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

980

0.77

1.45

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

980

0.77

1.45

1.4

—

(4034850) Laboratory test

179

1517

1.19

1.43

9.3

9.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

976

0.78

1.41

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

103

1.75

1.40

1.3

—

(3019174) dRVVT (LA screen)

2.25

1.40

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

142

1.62

1.38

1.3

93.60

85.56

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.94

1.36

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

298

1.41

1.35

1.6

1.5

90.71

82.09

umol/l

0.33

298

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

273

1.43

1.34

1.4

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

592

1.29

1.34

2.1

2.2

33.04

32.59

0.41

587

(3032057) Clostridioides difficile [Presence] in Stool

105

1.72

1.33

1.4

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

621

1.28

1.31

1.4

1.5

0.42

0.38

nmol/l

0.20

497

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.00

1.27

1.7

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

353

0.65

1.26

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

431

1.33

1.26

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1058

0.80

1.25

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

192

1663

1.16

1.22

1.7

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

272

1.40

1.19

1.4

1.6

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.31

1.18

1.0

45.67

60.90

u/l

—

(3044009) aPTT.lupus sensitive (LA screen)

2.11

1.18

1.4

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.11

1.18

4.1

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

2.11

1.18

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

805

0.78

1.17

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

827

0.78

1.17

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

802

0.78

1.15

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.85

1.13

1.0

1.1

—

(21494434) Karyotype in Bone marrow

422

1.31

1.12

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

537

1.27

1.12

1.4

1.3

—

(3035880) pH of Pleural fluid

267

1.39

1.12

1.2

1.3

—

(3024471) HLA-A [Type]

151

1.53

1.11

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.96

1.11

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.96

1.11

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

208

0.58

1.11

1.1

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.69

1.07

1.7

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

134

1144

1.18

1.05

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

101

1208

0.83

1.05

1.5

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.79

1.04

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

118

999

1.18

1.03

2.8

3.4

163.96

723.69

u/ml

1.16

107

912

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.83

1.02

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

122

1.56

1.02

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.92

1.02

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.69

1.01

1.4

1.5

4.17

8.10

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

123

1.55

0.99

5.4

7.2

—

(3044941) Cell count panel - Synovial fluid

738

1.21

0.98

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

156

1.48

0.98

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

620

1.23

0.98

1.1

2.87

3.23

u/ml

0.12

288

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

1.42

0.96

4.3

3.6

80.95

69.82

mg/l

0.37

132

(40757373) Influenza virus identified in Isolate

100

1.60

0.96

1.7

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

217

1.38

0.93

25.5

24.6

129.64

113.62

ug/l

0.55

177

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

347

1.30

0.93

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.00

0.87

3.7

4.5

2.38

2.50

mg/l

—

(3033799) Differential panel - Peritoneal fluid

153

1.44

0.85

1.5

2.0

—

(3044007) Cell count panel - Peritoneal fluid

145

1.45

0.84

1.6

2.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.94

0.84

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.78

0.84

1.0

—

(3042733) HLA Ab [Presence] in Serum

146

1.44

0.82

4.1

4.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

544

0.79

0.81

2.8

13.19

13.16

0.08

539

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

454

1.24

0.80

1.4

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

122

1.48

0.80

1.0

1.1

1.01

1.71

u/ml

0.27

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

123

1.46

0.77

1.4

1.3

46.90

30.58

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.64

0.75

4.3

5.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

670

1.18

0.74

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

735

1.17

0.73

1.1

3.62

5.39

u/ml

0.55

370

(3001556) Androgen free Index in Serum or Plasma

1.84

0.73

1.3

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

700

0.83

0.73

1.6

1.5

—

(3024932) HLA-DR beta [Type]

150

1.40

0.73

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

561

1.20

0.72

1.7

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.80

0.72

3.3

2.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.80

0.72

1.1

1.2

—

42.34

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

130

1148

1.14

0.72

2.2

2.3

138.50

112.75

ug/min

0.16

690

(21491868) Cryoglobulin [Mass/volume] in Serum

159

1.39

0.72

1.0

1.2

—

0.23

g/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

452

1.22

0.72

1.2

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.92

0.70

1.2

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

420

0.78

0.68

1.3

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

110

1.46

0.68

1.0

1.1

—

568.00

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

909

0.86

0.68

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

144

1.39

0.67

1.7

1.5

9.82

8.42

ug/l

0.48

144

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

612

1.18

0.67

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.59

0.65

1.4

1.3

159.57

167.92

mmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

134

1201

1.12

0.61

5.8

4.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

702

1.16

0.61

1.1

1.23

1.21

u/ml

0.01

287

(3027035) Albumin [Mass/time] in 24 hour Urine

1.60

0.61

1.3

—

640.53

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

113

1.42

0.61

1.3

1.4

22.02

25.43

g/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

280

1.25

0.60

1.0

—

(40758358) Immune stain study

0.00

0.60

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

105

1.43

0.60

1.6

2.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

186

0.70

0.59

1.1

—

(44813793) Dust mix specific IgE antibody measurement

308

1.24

0.59

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

201

1.29

0.58

1.2

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.58

0.0

1.3

—

4501.20

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

237

1.27

0.58

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

298

0.77

0.57

1.5

7.71

7.95

mmol/l

0.39

286

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

193

1.30

0.57

1.3

1.5

68.70

63.93

0.30

156

(3002523) Influenza virus A Ag [Presence] in Specimen

670

1.15

0.57

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

1.51

0.56

1.9

2.3

3.32

4.05

ug/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.57

0.56

1.4

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.57

0.56

2.8

6.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

316

0.79

0.52

1.3

1.4

158.87

192.33

pmol/l

0.48

316

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

205

1.27

0.52

1.0

1.1

3.22

6.44

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.45

0.51

6.3

7.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

173

1592

1.09

0.51

1.7

1.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.39

0.50

1.1

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.46

0.50

2.5

3.5

114.62

33.61

g/mol

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

660

1.14

0.49

1.2

1.1

0.89

1.83

u/ml

0.86

320

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

1.39

0.49

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

136

1.32

0.49

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

577

1.15

0.48

2.5

2.1

24.90

21.85

mg/l

0.17

139

(3051387) C reactive protein [Mass/volume] in Capillary blood

1035

0.90

0.46

4.3

3.4

23.74

27.36

mg/l

0.43

644

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

151

1389

1.09

0.46

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

302

1.19

0.44

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

113

1.33

0.42

2.1

2.2

6.57

7.76

mmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

528

1.14

0.42

1.1

3.57

4.85

u/ml

0.26

204

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

149

1.28

0.41

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.52

0.41

2.4

1.5

347.60

350.15

umol/24h

—

(3022475) Manganese [Moles/volume] in Blood

1.52

0.41

1.0

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.41

0.0

4.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.41

0.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

105

1.33

0.41

6.2

7.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

123

1.30

0.40

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.39

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.35

0.37

2.2

4.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.29

0.36

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.29

0.36

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.29

0.36

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

658

1.11

0.36

1.4

1.5

31.96

32.30

g/l

0.08

595

(3020874) Milk IgE Ab [Units/volume] in Serum

244

1.19

0.36

1.1

1.0

0.23

2.77

u/ml

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

869

1.09

0.36

2.8

3.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.27

0.36

1.8

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

328

1.16

0.36

2.3

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.33

0.33

2.2

2.6

0.33

0.64

u/field

—

(3025577) Chromium [Mass/volume] in Blood

293

1.16

0.33

1.7

2.1

1.71

2.19

ug/l

0.86

246

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

157

1473

1.07

0.33

1.4

—

(3047189) Immunofixation for 24 hour Urine

228

1.19

0.33

2.5

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

166

0.78

0.33

2.1

1.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.30

0.33

3.3

2.0

—

(3024263) Appearance of Synovial fluid

266

1.17

0.32

1.0

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

119

1.26

0.31

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

230

1.17

0.31

4.1

4.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.30

0.30

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.27

0.30

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.27

0.30

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

242

1.16

0.28

1.1

1.3

—

(3045788) Cell count panel - Pleural fluid

451

1.11

0.27

1.6

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

434

4208

1.03

0.27

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.70

0.26

1.4

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

613

0.91

0.25

1.4

1.3

7.82

7.32

mmol/l

0.46

540

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

378

1.11

0.24

1.4

2.1

4.12

1.77

u/field

0.80

150

(4281824) Cell count and differential, peritoneal fluid

493

1.10

0.24

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

244

0.86

0.24

1.9

1.5

—

(3012441) Differential panel - Pleural fluid

494

1.09

0.23

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

848

0.93

0.23

1.4

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

755

0.93

0.23

3.4

3.7

45.33

31.08

u/ml

0.36

732

(40761539) Cells [Type] in Urine sediment by Light microscopy

115

1.22

0.23

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.32

0.23

1.2

1.1

—

9.47

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.32

0.23

1.6

3.3

—

0.00

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.25

0.22

1.0

5.4

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.3

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

5.3

—

55.50

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.2

—

97.48

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.01

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

730

1.07

0.21

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

344

1.11

0.21

1.6

1.5

0.94

0.95

g/l

0.07

344

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

498

1.09

0.21

1.6

1.4

4.73

3.97

ug/l

0.13

438

(3022689) Creatine [Moles/volume] in Urine

145

0.83

0.21

1.2

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.31

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.24

0.20

1.1

1.2

—

(40768441) Liver Pathology biopsy report

354

1.10

0.20

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

282

0.89

0.20

1.1

1.3

1.58

1.56

g/l

0.12

282

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.25

0.20

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

108

1.20

0.20

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

520

0.92

0.19

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

241

1.12

0.19

1.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

241

1.12

0.19

1.1

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.13

0.18

1.5

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

579

1.07

0.18

1.1

3.06

3.20

u/ml

0.03

263

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.21

0.18

3.6

8.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

157

1.15

0.17

1.4

1.5

1.59

2.82

0.65

132

(3028308) Erythrocytes [#/volume] in Pleural fluid

514

1.07

0.16

1.5

12685.66

74041.15

e6/l

2.87

302

(40768793) Breast Pathology biopsy report

109

1042

1.05

0.16

1.2

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

169

1632

1.04

0.16

1.7

4.14

4.13

mg/l

0.00

135

1197

(3041806) Other cells [#/volume] in Blood by Manual count

139

1.15

0.16

1.7

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.08

0.14

1.4

2.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

576

1.06

0.14

1.5

1644.06

1827.00

e6/l

0.16

417

(3000034) Microalbumin [Mass/volume] in Urine

460

1.07

0.14

2.4

3.1

25.00

49.86

mg/l

0.90

347

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

276

1.09

0.13

4.7

6.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

823

1.05

0.13

1.2

1.1

0.27

2.39

u/ml

7.28

405

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

252

0.91

0.12

1.5

1.7

2.12

3.47

u/field

0.59

180

(40768800) Prostate Pathology biopsy report

997

0.96

0.12

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

465

0.95

0.11

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.09

0.09

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.06

0.09

2.2

2.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.05

0.08

11.8

13.2

4.95

5.56

mmol/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

253

1.07

0.08

1.5

1.3

5.60

5.85

mmol/l

0.69

242

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

146

1.10

0.08

4.7

3.2

6.35

7.08

mg/l

0.19

115

(3000285) Sodium [Moles/volume] in Blood

1.06

0.08

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

480

1.04

0.07

1.1

0.03

0.34

u/ml

2.81

138

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

344

1.05

0.06

1.1

1.3

12.70

13.12

u/l

0.07

316

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

129

1.09

0.05

1.0

1.1

0.54

14.47

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

238

1.05

0.05

1.3

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

179

1.06

0.05

1.0

1.1

—

(3016750) Collection duration of Urine

272

0.96

0.04

2.0

2.1

502.25

491.23

min

0.36

200

(3015076) Soybean IgE Ab [Units/volume] in Serum

209

1.05

0.04

1.1

1.0

0.22

1.88

u/ml

—

(3015183) Erythrocyte sedimentation rate

240

0.96

0.03

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

240

1.04

0.03

1.0

0.30

3.03

u/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

227

2288

0.99

0.03

1.4

1.7

—

(3020650) Glucose [Presence] in Urine

122

1.07

0.02

1.2

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

237

0.97

0.01

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

802

1.00

0.00

1.6

1.7

—

(3004775) Volume in Urine collected for unspecified duration

375

1.01

0.00

2.4

2.2

653.34

626.28

0.15

248

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.04

0.00

1.4

1.2

2.18

1.62

mmol/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

144

0.97

0.00

1.4

1.2

44.81

39.13

g/l

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

2.64

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1432.86

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.91

-0.00

1.6

3.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.7

—

0.23

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.94

-0.00

1.8

2.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3014891) Appearance of Pleural fluid

0.92

-0.00

1.5

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.02

-0.00

1.8

2.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_DIPLOPIA and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_DIPLOPIA	1.261 [1.14, 1.39]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.297

During the follow-up period (1.1.1998 — 31.12.2019), 2368 out of 13939 females with H7_DIPLOPIA died.

Males

Parameter	HR [95% CI]	p-value
H7_DIPLOPIA	1.231 [1.11, 1.36]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 2994 out of 13545 males with H7_DIPLOPIA died.

Mortality risk

Mortality risk for people of age

years, who have H7_DIPLOPIA.

N-year risk	Females	Males
1	0.156%	0.261%
5	0.883%	1.563%
10	2.033%	3.62%
15	3.659%	6.976%
20	6.374%	11.805%

Relationships between endpoints

↥

Index endpoint: H7_DIPLOPIA – Diplopia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diplopia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints